N-CSRS 1 d820671dncsrs.htm BLACKROCK FUNDS BLACKROCK FUNDS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-05742

 

Name of Fund:   BlackRock FundsSM
  BlackRock Advantage Small Cap Growth Fund

 

Fund Address:   100 Bellevue Parkway, Wilmington, DE 19809

Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock FundsSM,
50 Hudson Yards, New York, NY 10001

Registrant’s telephone number, including area code: (800) 441-7762

Date of fiscal year end: 09/30/2024

Date of reporting period: 03/31/2024


Item 1 – Report to Stockholders

(a) The Report to Shareholders is attached herewith.

 


 

LOGO

  MARCH 31, 2024

 

  

2024 Semi-Annual Report

(Unaudited)

 

BlackRock FundsSM

 

·  

BlackRock Advantage Small Cap Growth Fund

 

 

 

 

 

 

 

 

Not FDIC Insured • May Lose Value • No Bank Guarantee


The Markets in Review

Dear Shareholder,

The combination of continued economic growth and cooling inflation provided a supportive backdrop for investors during the 12-month reporting period ended March 31, 2024. Higher interest rates helped to rein in inflation, and the Consumer Price Index decelerated substantially while remaining above pre-pandemic levels. A moderating labor market helped ease inflationary pressure, although wages continued to grow. Wage and job growth powered robust consumer spending, backstopping the economy. On October 7, 2023, Hamas launched a horrific attack on Israel. The ensuing war has had a significant humanitarian impact and could lead to heightened economic and market volatility. We see geopolitics as a structural market risk going forward. See our geopolitical risk dashboard at blackrock.com for more details.

Equity returns were robust during the period, as interest rates stabilized and the economy proved to be more resilient than many investors expected. The U.S. economy continued to show strength, and growth further accelerated in the second half of 2023. Large-capitalization U.S. stocks posted particularly substantial gains, supported by the performance of a few notable technology companies, while small-capitalization U.S. stocks’ advance was slower but still robust. Meanwhile, international developed market equities also gained strongly, while emerging market stocks advanced at a more modest pace.

The 10-year U.S. Treasury yield rose during the reporting period, as investors reacted to elevated inflation and attempted to anticipate future interest rate changes. However, higher yields drove positive returns overall for 10-year U.S. Treasuries and solid gains in shorter-duration U.S. Treasuries. The corporate bond market benefited from improving economic sentiment, although high-yield corporate bond prices fared significantly better than investment-grade bonds as demand from yield-seeking investors remained strong.

The U.S. Federal Reserve (the “Fed”), attempting to manage persistent inflation, raised interest rates twice during the 12-month period, but paused its tightening after its July meeting. The Fed also continued to reduce its balance sheet by not replacing some of the securities that reach maturity.

Supply constraints appear to have become an embedded feature of the new macroeconomic environment, making it difficult for developed economies to increase production without sparking higher inflation. Geopolitical fragmentation and an aging population risk further exacerbating these constraints, keeping the labor market tight and wage growth high. Although the Fed has stopped tightening for now, we believe that the new economic regime means that the Fed will need to maintain high rates for an extended period despite the market’s hopes for rapid interest rate cuts, as reflected in the ongoing rally. In this new regime, we anticipate greater volatility and dispersion of returns, creating more opportunities for selective portfolio management.

Looking at developed market stocks, we have an overweight stance on U.S. stocks overall, particularly given the promise of emerging AI technologies. We are also overweight Japanese stocks as shareholder-friendly policies generate increased investor interest, although we maintain an underweight stance on European stocks. In credit, there are selective opportunities in the near term despite tighter credit and financial conditions. For fixed income investing with a six- to twelve-month horizon, we see the most attractive investments in short-term U.S. Treasuries and hard-currency emerging market bonds.

Overall, our view is that investors need to think globally, position themselves to be prepared for a decarbonizing economy, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

 

Total Returns as of March 31, 2024

 

    

 

 6-Month 

 

 

 

 12-Month 

 

U.S. large cap equities
(S&P 500® Index)

  23.48%    29.88%

U.S. small cap equities
(Russell 2000® Index)

  19.94      19.71  

International equities
(MSCI Europe, Australasia, Far East Index)

  16.81      15.32  

Emerging market equities
(MSCI Emerging Markets Index)

  10.42      8.15  

3-month Treasury bills
(ICE BofA 3-Month U.S. Treasury Bill Index)

  2.68      5.24  

U.S. Treasury securities
(ICE BofA 10-Year U.S. Treasury Index)

  4.88      (2.44)  

U.S. investment grade bonds (Bloomberg U.S. Aggregate Bond Index)

  5.99      1.70  

Tax-exempt municipal bonds (Bloomberg Municipal Bond Index)

  7.48      3.13  

U.S. high yield bonds
(Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

  8.73      11.15  

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

2  

T H I S P A G E I S N O T P A R T O F  Y O U R F U N D R E P O R T


Table of Contents

 

     

Page

 

 

The Markets in Review

     2  

Semi-Annual Report:

  

Fund Summary

     4  

About Fund Performance

     6  

Disclosure of Expenses

     6  

Derivative Financial Instruments

     6  

Financial Statements:

  

Schedule of Investments

     7  

Statement of Assets and Liabilities

     17  

Statement of Operations

     19  

Statements of Changes in Net Assets

     20  

Financial Highlights

     21  

Notes to Financial Statements

     25  

Statement Regarding Liquidity Risk Management Program

     34  

Additional Information

     35  

Glossary of Terms Used in this Report

     37  

 

 

 

 

LOGO

 

 

 

 

  3


Fund Summary  as of March 31, 2024    BlackRock Advantage Small Cap Growth Fund

 

Investment Objective

BlackRock Advantage Small Cap Growth Fund’s (the “Fund”) investment objective is to seek long-term capital growth.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended March 31, 2024, all of the Fund’s share classes outperformed its benchmark, the Russell 2000® Growth Index.

What factors influenced performance?

Equities broadly delivered impressive returns as investors embraced a positive outlook for the global economy and the prospects for technological innovation. The market rally was supported by the view that policy makers had successfully navigated the challenges of rising inflation and slowing growth, avoiding a hard landing. The U.S. market led the way, driven by the exceptional performance of mega-cap technology stocks, which benefited from breakthroughs in artificial intelligence (“AI”) and cloud computing. Large-cap stocks continued to outperform small caps. In factor terms, growth and size continued to dominate, while momentum and earnings yield also performed well. However, the market trends were not uniform, as performance among the largest technology stocks diverged and some sectors faced headwinds from geopolitical risks, such as the conflicts in the Middle East.

The main drivers of the Fund’s outperformance during the reporting period were insights related to sentiment and fundamental valuation. Sentiment insights, which capture the mood of analysts, investors, and consumers from various textual and social media sources, performed especially well in the consumer discretionary and industrials sectors. Fundamental valuation insights, which focus on companies with strong sales, cash flow, and financial statements, as well as those investing in research and development, were especially effective within the information technology sector.

Insights that detracted from performance included some of those related to macro-thematic and fundamental quality measures. Macro-thematic insights that favored companies in the AI ecosystem faced challenges, particularly within the telecommunication services sector. Fundamental quality insights that favored companies with longer-term debt maturities underperformed as they contributed to an underweight position in utilities, which was one of the best-performing sectors in the second half of the period. Sentiment insights that analyzed the text of analyst reports had mixed results, driving an overweight in the healthcare sector, which faced regulatory and political headwinds early in the period before rebounding.

Describe recent portfolio activity.

The Fund maintained a balanced allocation of risk across all major drivers of return during the reporting period. However, several new stock selection insights were added to the Fund. In this vein, the Fund developed insights to assist in analyzing the impact of trade disruption related to the Red Sea route, utilizing a large language model to identify the winners and losers from the increased shipping costs and delays. This included capturing the exposure of different firms to the Red Sea route, as well as their ability to adapt to alternative routes or modes of transportation.

Describe portfolio positioning at period end.

Relative to the Russell 2000® Growth Index, the Fund’s positioning remained largely sector neutral. The Fund maintained slight overweight positions in healthcare and information technology, while maintaining slight underweight positions in the energy and financials sectors.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Performance

 

                Average Annual Total Returns(a)(b)  
                1 Year           5 Years           10 Years  
     6-Month
Total
Returns
           Without
Sales
Charge
    With
Sales
Charge
           Without
Sales
Charge
    With
Sales
Charge
           Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    23.25       21.78     N/A         8.55     N/A         8.11     N/A  

Investor A

    23.15         21.52       15.14       8.27       7.11       7.82       7.24

Class K

    23.31         21.84       N/A         8.62       N/A         8.14       N/A  

Class R

    22.99         21.13       N/A         8.02       N/A         7.57       N/A  

Russell 2000® Growth Index(c)

    21.30               20.35       N/A               7.38       N/A               7.89       N/A  

 

(a) Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

(b) Under normal circumstances, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of small cap companies and at least 80% of its net assets (plus any borrowings for investment purposes) in securities or instruments of issuers located in the United States.

(c)  An index that measures performance of the small-cap growth segment of the U.S. equity universe. It includes those Russell 2000® Index companies with higher price-to-value ratios and higher forecasted growth values.

 

N/A — Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

  

  

   

 

 

 

 

 

4  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Fund Summary  as of March 31, 2024 (continued)    BlackRock Advantage Small Cap Growth Fund

 

Expense Example

 

    Actual           Hypothetical 5% Return           
     

Beginning
Account Value
(10/01/23)
 
 
 
    

Ending
Account Value
(03/31/24)
 
 
 
    

Expenses
Paid During
the Period
 
 
(a) 
           

Beginning
Account Value
(10/01/23)
 
 
 
    

Ending
Account Value
(03/31/24)
 
 
 
    

Expenses
Paid During
the Period
 
 
(a) 
      

Annualized
Expense
Ratio
 
 
 

Institutional

  $ 1,000.00      $ 1,232.50      $ 2.79       $ 1,000.00      $ 1,022.50      $ 2.53          0.50

Investor A

    1,000.00        1,231.50        4.18         1,000.00        1,021.25        3.79          0.75  

Class K

    1,000.00        1,233.10        2.51         1,000.00        1,022.75        2.28          0.45  

Class R

    1,000.00        1,229.90        5.57               1,000.00        1,020.00        5.05          1.00  

 

(a) For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/366 (to reflect the one-half year period shown).

  

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

Security(a)   Percent of
Net Assets
 

Super Micro Computer, Inc.

    3.7

MicroStrategy, Inc., Class A

    1.7  

ExlService Holdings, Inc.

    1.0  

Installed Building Products, Inc.

    1.0  

Comfort Systems U.S.A., Inc.

    1.0  

Visteon Corp.

    1.0  

Insperity, Inc.

    1.0  

Flowserve Corp.

    0.9  

Atkore, Inc.

    0.9  

Fluor Corp.

    0.8  

SECTOR ALLOCATION

 

Sector(b)   Percent of
Net Assets
 

Information Technology

    25.5

Health Care

    22.3  

Industrials

    21.2  

Consumer Discretionary

    11.9  

Financials

    5.0  

Consumer Staples

    3.4  

Materials

    3.3  

Energy

    3.1  

Communication Services

    2.3  

Other (each representing less than 1%)

    1.1  

Short-Term Securities

    4.1  

Liabilities in Excess of Other Assets

    (3.2
 

 

(a) 

Excludes short-term investments.

 
(b) 

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

 

F U N D S U M M A R Y

  5


About Fund Performance

 

Institutional and Class K Shares are not subject to any sales charge. These shares bear no ongoing distribution or service fees and are available only to certain eligible investors. Class K Shares performance shown prior to the Class K Shares inception date of January 25, 2018 is that of Institutional Shares. The performance of the Fund’s Class K Shares would be substantially similar to Institutional Shares because Class K Shares and Institutional Shares invest in the same portfolio of securities and performance would only differ to the extent that Class K Shares and Institutional Shares have different expenses. The actual returns of Class K Shares would have been higher than those of the Institutional Shares because Class K Shares have lower expenses than the Institutional Shares.

Investor A Shares are subject to a maximum initial sales charge (front-end load) of 5.25% and a service fee of 0.25% per year (but no distribution fee). Certain redemptions of these shares may be subject to a contingent deferred sales charge (“CDSC”) where no initial sales charge was paid at the time of purchase. These shares are generally available through financial intermediaries.

Class R Shares are not subject to any sales charge. These shares are subject to a distribution fee of 0.25% per year and a service fee of 0.25% per year. These shares are available only to certain employer-sponsored retirement plans. Class R Shares performance shown prior to the Class R Shares inception date of March 2, 2018 is that of Institutional Shares and was restated to reflect Class R Shares fees.

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of the Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Refer to blackrock.com to obtain performance data current to the most recent month-end. Performance results do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Figures shown in the performance tables assume reinvestment of all distributions, if any, at net asset value (“NAV”) on the ex-dividend date or payable date, as applicable. Investment return and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Distributions paid to each class of shares will vary because of the different levels of service, distribution and transfer agency fees applicable to each class, which are deducted from the income available to be paid to shareholders.

BlackRock Advisors, LLC (the “Manager”), the Fund’s investment adviser, has contractually and/or voluntarily agreed to waive and/or reimburse a portion of the Fund’s expenses. Without such waiver(s) and/or reimbursement(s), the Fund’s performance would have been lower. With respect to the Fund’s voluntary waiver(s), if any, the Manager is under no obligation to waive and/or reimburse or to continue waiving and/or reimbursing its fees and such voluntary waiver(s) may be reduced or discontinued at any time. With respect to the Fund’s contractual waiver(s), if any, the Manager is under no obligation to continue waiving and/or reimbursing its fees after the applicable termination date of such agreement. See the Notes to Financial Statements for additional information on waivers and/or reimbursements.

Disclosure of Expenses

Shareholders of the Fund may incur the following charges: (a) transactional expenses, such as sales charges; and (b) operating expenses, including investment advisory fees, administration fees, service and distribution fees, including 12b-1 fees, acquired fund fees and expenses, and other fund expenses. The expense example shown (which is based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) is intended to assist shareholders both in calculating expenses based on an investment in the Fund and in comparing these expenses with similar costs of investing in other mutual funds.

The expense example provides information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number corresponding to their share class under the heading entitled “Expenses Paid During the Period.”

The expense example also provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in the Fund and other funds, compare the 5% hypothetical example with the 5% hypothetical examples that appear in shareholder reports of other funds.

The expenses shown in the expense example are intended to highlight shareholders’ ongoing costs only and do not reflect transactional expenses, such as sales charges, if any. Therefore, the hypothetical example is useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

Derivative Financial Instruments

The Fund may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Fund’s successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Fund can realize on an investment and/or may result in lower distributions paid to shareholders. The Fund’s investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

 

 

6  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Schedule of Investments (unaudited)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   
Aerospace & Defense — 0.4%            

AeroVironment, Inc.(a)

    813     $ 124,616  

BWX Technologies, Inc.

    819       84,046  

Moog, Inc., Class A

    13,132       2,096,524  
   

 

 

 
       2,305,186  
Air Freight & Logistics — 0.0%            

GXO Logistics, Inc.(a)

    2,232       119,992  
   

 

 

 
Automobile Components — 2.2%            

Adient PLC(a)

    66,831       2,200,077  

Dana, Inc.

    113,336       1,439,367  

Fox Factory Holding Corp.(a)

    6,542       340,642  

Gentherm, Inc.(a)

    17,964       1,034,367  

Lear Corp.

    3,900       565,032  

Modine Manufacturing Co.(a)(b)

    10,895       1,037,095  

Patrick Industries, Inc.

    5,524       659,952  

Visteon Corp.(a)

    48,154       5,663,392  
   

 

 

 
      12,939,924  
Banks — 0.2%            

Coastal Financial Corp.(a)

    2,237       86,952  

HomeTrust Bancshares, Inc.

    17,508       478,669  

Lakeland Bancorp, Inc.

    9,083       109,904  

OceanFirst Financial Corp.

    21,332       350,058  
   

 

 

 
      1,025,583  
Beverages — 0.8%            

Coca-Cola Consolidated, Inc.

    2,072       1,753,762  

MGP Ingredients, Inc.

    8,448       727,626  

National Beverage Corp.(a)

    32,239       1,530,063  

Primo Water Corp.

    38,277       697,024  
   

 

 

 
      4,708,475  
Biotechnology — 11.0%            

ACADIA Pharmaceuticals, Inc.(a)

    98,277       1,817,142  

ADMA Biologics, Inc.(a)

    42,873       282,962  

Affimed NV(a)

    12,710       67,363  

Akero Therapeutics, Inc.(a)

    14,209       358,919  

Alector, Inc.(a)

    117,246       705,821  

Alkermes PLC(a)

    53,236       1,441,099  

Alpine Immune Sciences, Inc.(a)

    15,404       610,615  

Amicus Therapeutics, Inc.(a)

    111,557       1,314,141  

Anika Therapeutics, Inc.(a)

    19,770       502,158  

Arcellx, Inc.(a)

    12,375       860,681  

Arcturus Therapeutics Holdings, Inc.(a)

    24,877       840,096  

Arcus Biosciences, Inc.(a)

    37,110       700,637  

Arcutis Biotherapeutics, Inc.(a)

    5,099       50,531  

Ardelyx, Inc.(a)

    38,006       277,444  

Arrowhead Pharmaceuticals, Inc.(a)

    41,069       1,174,573  

Astria Therapeutics, Inc.(a)

    16,188       227,846  

Aurinia Pharmaceuticals, Inc.(a)

    7,877       39,464  

Beam Therapeutics, Inc.(a)(b)

    28,314       935,495  

BioCryst Pharmaceuticals, Inc.(a)

    186,961       949,762  

Biomea Fusion, Inc.(a)

    119       1,779  

Blueprint Medicines Corp.(a)

    35,457       3,363,451  

Bridgebio Pharma, Inc.(a)

    18,832       582,285  

Cabaletta Bio, Inc.(a)

    9,235       157,549  

CareDx, Inc.(a)

    30,404       321,978  

Catalyst Pharmaceuticals, Inc.(a)

    56,757       904,707  

Celldex Therapeutics, Inc.(a)

    23       965  

Cerevel Therapeutics Holdings, Inc.(a)

    18,427       778,909  

CG oncology, Inc.(a)

    7,131       313,051  

Chinook Therapeutics, Inc., CVR(a)(c)

    7,289       3,207  

Coherus Biosciences, Inc.(a)

    137,175       327,848  
Security   Shares     Value  
Biotechnology (continued)            

Cytokinetics, Inc.(a)

    33,272     $  2,332,700  

Day One Biopharmaceuticals, Inc.(a)

    8,055       133,069  

Deciphera Pharmaceuticals, Inc.(a)

    77,396       1,217,439  

Denali Therapeutics, Inc.(a)

    103,838       2,130,756  

Dynavax Technologies Corp.(a)(b)

    92,899       1,152,877  

Dyne Therapeutics, Inc.(a)

    1,818       51,613  

Entrada Therapeutics, Inc.(a)

    140       1,984  

Exelixis, Inc.(a)

    522       12,387  

Fate Therapeutics, Inc.(a)

    42,166       309,498  

Halozyme Therapeutics, Inc.(a)

    70,764       2,878,680  

Ideaya Biosciences, Inc.(a)(b)

    27,414       1,202,926  

Immunovant, Inc.(a)

    17,469       564,423  

Inhibrx, Inc.(a)

    196       6,852  

Insmed, Inc.(a)

    54,600       1,481,298  

Intellia Therapeutics, Inc.(a)

    45,163       1,242,434  

Ionis Pharmaceuticals, Inc.(a)

    6,619       286,934  

Ironwood Pharmaceuticals, Inc., Class A(a)

    57,321       499,266  

iTeos Therapeutics, Inc.(a)

    82,831       1,129,815  

Keros Therapeutics, Inc.(a)

    2,785       184,367  

Kiniksa Pharmaceuticals Ltd., Class A(a)

    52,837       1,042,474  

Kronos Bio, Inc.(a)

    17,065       22,185  

Krystal Biotech, Inc.(a)

    6,039       1,074,519  

Kura Oncology, Inc.(a)

    14,461       308,453  

Kymera Therapeutics, Inc.(a)

    19,348       777,790  

Kyverna Therapeutics, Inc.(a)

    4,082       101,397  

Madrigal Pharmaceuticals, Inc.(a)(b)

    4,162       1,111,420  

MeiraGTx Holdings PLC(a)

    17,017       103,293  

MiMedx Group, Inc.(a)

    25,315       194,925  

Mineralys Therapeutics, Inc.(a)

    141       1,820  

Morphic Holding, Inc.(a)

    405       14,256  

Natera, Inc.(a)

    10,328       944,599  

Nurix Therapeutics, Inc.(a)

    11,410       167,727  

Nuvalent, Inc., Class A(a)

    5,176       388,666  

Poseida Therapeutics, Inc.(a)

    21,718       69,280  

Prelude Therapeutics, Inc.(a)

    4,712       22,335  

Protagonist Therapeutics, Inc.(a)

    12,615       364,952  

Prothena Corp. PLC(a)

    8,450       209,306  

PTC Therapeutics, Inc.(a)

    51,217       1,489,903  

Puma Biotechnology, Inc.(a)

    42,932       227,540  

Relay Therapeutics, Inc.(a)

    83,046       689,282  

REVOLUTION Medicines, Inc.(a)

    26,128       842,105  

Rhythm Pharmaceuticals, Inc.(a)

    17,706       767,201  

Rigel Pharmaceuticals, Inc.(a)

    261,229       386,619  

Rocket Pharmaceuticals, Inc.(a)

    4,967       133,811  

Sarepta Therapeutics, Inc.(a)

    1,033       133,732  

SpringWorks Therapeutics, Inc.(a)

    19,351       952,456  

Sutro Biopharma, Inc.(a)

    52,266       295,303  

Syndax Pharmaceuticals, Inc.(a)

    69,719       1,659,312  

TG Therapeutics, Inc.(a)(b)

    74,355       1,130,940  

Travere Therapeutics, Inc.(a)

    107,181       826,366  

Twist Bioscience Corp.(a)

    9,491       325,636  

Ultragenyx Pharmaceutical, Inc.(a)

    7,435       347,140  

United Therapeutics Corp.(a)

    4,116       945,528  

Vanda Pharmaceuticals, Inc.(a)

    153,130       629,364  

Vaxcyte, Inc.(a)

    38,398       2,622,967  

Vera Therapeutics, Inc., Class A(a)

    141       6,080  

Veracyte, Inc.(a)

    25,340       561,534  

Vericel Corp.(a)

    28,793       1,497,812  

Viking Therapeutics, Inc.(a)

    39,795       3,263,190  

Vir Biotechnology, Inc.(a)

    46,227       468,280  
 

 

 

S C H E D U L E O F I N V E S T M E N T S

  7


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Biotechnology (continued)            

Voyager Therapeutics, Inc.(a)

    46,823     $ 435,922  

Xencor, Inc.(a)

    51,991       1,150,561  
   

 

 

 
       65,439,777  
Broadline Retail — 0.2%            

Dillard’s, Inc., Class A

    1,754       827,257  

Kohl’s Corp.

    13,250       386,237  
   

 

 

 
      1,213,494  
Building Products — 2.4%            

AAON, Inc.

    9,805       863,821  

American Woodmark Corp.(a)

    11,377       1,156,586  

Apogee Enterprises, Inc.

    18,374       1,087,741  

AZEK Co., Inc. (The), Class A(a)

    9,893       496,826  

Caesarstone Ltd.(a)

    1,695       6,933  

CSW Industrials, Inc.

    69       16,187  

Gibraltar Industries, Inc.(a)

    36,848       2,967,369  

Janus International Group, Inc.(a)(b)

    170,868       2,585,233  

JELD-WEN Holding, Inc.(a)(b)

    40,663       863,275  

Masonite International Corp.(a)

    8,469       1,113,250  

UFP Industries, Inc.

    25,058       3,082,385  
   

 

 

 
      14,239,606  
Capital Markets — 1.0%            

Brightsphere Investment Group, Inc.

    26,497       605,192  

Donnelley Financial Solutions, Inc.(a)

    15,260       946,273  

Evercore, Inc., Class A

    959       184,694  

Federated Hermes, Inc., Class B

    8,495       306,839  

GCM Grosvenor, Inc., Class A

    9,571       92,456  

Hamilton Lane, Inc., Class A

    13,782       1,554,058  

Houlihan Lokey, Inc., Class A

    286       36,662  

Patria Investments Ltd., Class A

    43,790       649,844  

PJT Partners, Inc., Class A

    11,336       1,068,531  

Victory Capital Holdings, Inc., Class A

    13,907       590,074  
   

 

 

 
      6,034,623  
Chemicals — 1.9%            

Cabot Corp.

    44,424       4,095,893  

Hawkins, Inc.

    1,607       123,418  

Ingevity Corp.(a)

    13,472       642,614  

Innospec, Inc.

    1,854       239,055  

Minerals Technologies, Inc.

    11,145       838,996  

Mosaic Co. (The)

    34,538       1,121,103  

Quaker Chemical Corp.

    19,900       4,084,475  
   

 

 

 
      11,145,554  
Commercial Services & Supplies — 0.4%            

Brink’s Co. (The)

    2,471       228,271  

Cimpress PLC(a)

    198       17,525  

Healthcare Services Group, Inc.(a)

    112,877       1,408,705  

Li-Cycle Holdings Corp.(a)

    266,929       274,937  

Steelcase, Inc., Class A

    10,641       139,184  

Viad Corp.(a)

    3,230       127,553  
   

 

 

 
      2,196,175  
Communications Equipment — 0.6%            

Calix, Inc.(a)

    53,416       1,771,274  

Infinera Corp.(a)

    7,002       42,222  

NETGEAR, Inc.(a)

    91,241       1,438,871  

Viavi Solutions, Inc.(a)

    21,237       193,044  
   

 

 

 
      3,445,411  
Construction & Engineering — 4.0%            

AECOM

    4,107       402,815  

Argan, Inc.

    2,224       112,401  

Comfort Systems U.S.A., Inc.

    17,826       5,663,499  
Security   Shares     Value  
Construction & Engineering (continued)            

Construction Partners, Inc., Class A(a)(b)

    37,334     $ 2,096,304  

Dycom Industries, Inc.(a)(b)

    7,903       1,134,318  

EMCOR Group, Inc.

    5,821       2,038,514  

Fluor Corp.(a)

    114,658       4,847,740  

IES Holdings, Inc.(a)

    685       83,323  

MasTec, Inc.(a)

    6,057       564,815  

MYR Group, Inc.(a)(b)

    20,227       3,575,122  

Primoris Services Corp.

    38,891       1,655,590  

Sterling Infrastructure, Inc.(a)

    14,374       1,585,596  

Tutor Perini Corp.(a)

    620       8,965  
   

 

 

 
       23,769,002  
Consumer Finance — 1.2%            

Enova International, Inc.(a)

    22,604       1,420,209  

EZCORP, Inc., Class A, NVS(a)

    145,546       1,649,036  

FirstCash Holdings, Inc.

    24,449       3,118,226  

PROG Holdings, Inc.

    17,343       597,293  

Regional Management Corp.

    21,667       524,558  
   

 

 

 
      7,309,322  
Consumer Staples Distribution & Retail — 0.4%        

Performance Food Group Co.(a)

    12,448       929,119  

PriceSmart, Inc.

    11,605       974,820  

Sprouts Farmers Market, Inc.(a)

    4,719       304,281  
   

 

 

 
      2,208,220  
Diversified Consumer Services — 2.3%            

Chegg, Inc.(a)

    44,178       334,427  

Coursera, Inc.(a)

    72,706       1,019,338  

Duolingo, Inc., Class A(a)

    14,348       3,164,882  

Frontdoor, Inc.(a)

    123,775       4,032,590  

Laureate Education, Inc., Class A

    289,734       4,221,424  

OneSpaWorld Holdings Ltd.(a)

    26,910       356,019  

Stride, Inc.(a)

    6,520       411,086  

Universal Technical Institute, Inc.(a)

    1,875       29,888  
   

 

 

 
      13,569,654  
Diversified Telecommunication Services — 0.3%        

Bandwidth, Inc., Class A(a)

    21,569       393,850  

Cogent Communications Holdings, Inc.

    4,650       303,785  

Ooma, Inc.(a)

    142,750       1,217,657  
   

 

 

 
      1,915,292  
Electric Utilities — 0.2%            

PNM Resources, Inc.

    35,585       1,339,419  
   

 

 

 
Electrical Equipment — 2.3%            

Allient, Inc.

    16,328       582,583  

Atkore, Inc.(b)

    28,881       5,497,787  

Encore Wire Corp.(b)

    4,159       1,092,902  

EnerSys

    45,486       4,296,608  

NEXTracker, Inc., Class A(a)

    33,686       1,895,511  

Vicor Corp.(a)

    3,025       115,676  
   

 

 

 
      13,481,067  
Electronic Equipment, Instruments & Components — 4.1%  

Arlo Technologies, Inc.(a)

    8,125       102,781  

Avnet, Inc.

    19,625       973,007  

Badger Meter, Inc.

    14,431       2,335,080  

ePlus, Inc.(a)

    875       68,723  

Fabrinet(a)

    17,848       3,373,629  

FARO Technologies, Inc.(a)

    27,850       599,054  

Flex Ltd.(a)

    76,017       2,174,846  

Insight Enterprises, Inc.(a)

    22,579       4,188,856  

Itron, Inc.(a)

    21,666       2,004,538  

Kimball Electronics, Inc.(a)

    31,281       677,234  
 

 

 

8  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Electronic Equipment, Instruments & Components (continued)  

OSI Systems, Inc.(a)

    9,608     $ 1,372,215  

PC Connection, Inc.

    23,547       1,552,454  

Plexus Corp.(a)

    12,487       1,184,017  

Sanmina Corp.(a)

    53,020       3,296,784  

TTM Technologies, Inc.(a)

    46,308       724,720  
   

 

 

 
       24,627,938  
Energy Equipment & Services — 0.8%            

Archrock, Inc.

    36,155       711,169  

Borr Drilling Ltd.

    19,342       132,493  

Cactus, Inc., Class A

    8,275       414,495  

Forum Energy Technologies, Inc.(a)

    110       2,198  

Helix Energy Solutions Group, Inc.(a)

    7,709       83,565  

Kodiak Gas Services, Inc.

    1       27  

Liberty Energy, Inc., Class A

    63,274       1,311,037  

NOV, Inc.

    36,983       721,908  

Oceaneering International, Inc.(a)

    15,147       354,440  

Oil States International, Inc.(a)

    1,655       10,195  

Patterson-UTI Energy, Inc.

    941       11,235  

ProPetro Holding Corp.(a)

    60,323       487,410  

RPC, Inc.

    74,134       573,797  
   

 

 

 
      4,813,969  
Entertainment — 0.2%            

Eventbrite, Inc., Class A(a)

    3,657       20,041  

Lions Gate Entertainment Corp., Class A(a)

    15,634       155,558  

Lions Gate Entertainment Corp., Class B, NVS(a)

    46,381       431,807  

Playstudios, Inc., Class A(a)

    3,412       9,485  

Roku, Inc., Class A(a)

    8,969       584,510  
   

 

 

 
      1,201,401  
Financial Services — 1.7%            

Euronet Worldwide, Inc.(a)

    6,382       701,573  

EVERTEC, Inc.

    20,005       798,199  

I3 Verticals, Inc., Class A(a)

    3,612       82,679  

International Money Express, Inc.(a)

    21,125       482,284  

NMI Holdings, Inc., Class A(a)

    41       1,326  

Pagseguro Digital Ltd., Class A(a)

    272,620       3,893,014  

StoneCo Ltd., Class A(a)

    234,582       3,896,407  
   

 

 

 
      9,855,482  
Food Products — 1.6%            

John B Sanfilippo & Son, Inc.

    8       847  

Lancaster Colony Corp.

    18,820       3,907,597  

Pilgrim’s Pride Corp.(a)

    4,706       161,510  

Simply Good Foods Co. (The)(a)

    64,288       2,187,721  

SunOpta, Inc.(a)

    132,173       908,028  

Vital Farms, Inc.(a)

    92,128       2,141,976  
   

 

 

 
      9,307,679  
Gas Utilities — 0.1%            

Brookfield Infrastructure Corp., Class A

    10,635       383,285  

New Jersey Resources Corp.

    12,350       529,939  
   

 

 

 
      913,224  
Ground Transportation — 0.0%            

ArcBest Corp.

    487       69,397  
   

 

 

 
Health Care Equipment & Supplies — 3.5%            

Accuray, Inc.(a)

    106,313       262,593  

AngioDynamics, Inc.(a)

    109,419       642,289  

AtriCure, Inc.(a)

    25,181       766,006  

Axogen, Inc.(a)

    28,370       228,946  

Axonics, Inc.(a)

    21,766       1,501,201  

Cerus Corp.(a)

    158,498       299,561  

CONMED Corp.

    12,252       981,140  
Security   Shares     Value  
Health Care Equipment & Supplies (continued)            

Envista Holdings Corp.(a)

    52,350     $ 1,119,243  

Glaukos Corp.(a)

    1,195       112,677  

Haemonetics Corp.(a)

    12,291       1,049,037  

Inari Medical, Inc.(a)

    14,296       685,922  

Inmode Ltd.(a)

    34,901       754,211  

Inogen, Inc.(a)

    7       56  

Inspire Medical Systems, Inc.(a)

    3,652       784,413  

Insulet Corp.(a)

    762       130,607  

iRadimed Corp.

    28,665       1,260,973  

iRhythm Technologies, Inc.(a)

    5,445       631,620  

Lantheus Holdings, Inc.(a)

    32,883       2,046,638  

LeMaitre Vascular, Inc.

    26,352       1,748,719  

LivaNova PLC(a)

    3,577       200,097  

Merit Medical Systems, Inc.(a)

    30,529       2,312,572  

Nevro Corp.(a)

    7,861       113,513  

Omnicell, Inc.(a)

    17,120       500,418  

RxSight, Inc.(a)

    10,720       552,938  

SI-BONE, Inc.(a)

    42,041       688,211  

STAAR Surgical Co.(a)

    6,151       235,460  

Tactile Systems Technology, Inc.(a)

    14,018       227,792  

TransMedics Group, Inc.(a)

    10,302       761,730  

Treace Medical Concepts, Inc.(a)

    1,031       13,455  
   

 

 

 
       20,612,038  
Health Care Providers & Services — 3.5%            

23andMe Holding Co., Class A(a)

    138       74  

Accolade, Inc.(a)

    32,346       338,986  

Addus HomeCare Corp.(a)

    4,869       503,163  

Alignment Healthcare, Inc.(a)

    64,052       317,698  

AMN Healthcare Services, Inc.(a)

    7,468       466,825  

Castle Biosciences, Inc.(a)

    28,902       640,179  

CorVel Corp.(a)

    7,372       1,938,541  

Cross Country Healthcare, Inc.(a)(b)

    8,607       161,123  

Ensign Group, Inc. (The)

    13,589       1,690,743  

Guardant Health, Inc.(a)

    72,628       1,498,316  

HealthEquity, Inc.(a)

    26,817       2,189,072  

Hims & Hers Health, Inc., Class A(a)

    84,180       1,302,265  

Option Care Health, Inc.(a)

    57,310       1,922,177  

PetIQ, Inc., Class A(a)

    33,965       620,880  

Privia Health Group, Inc.(a)(b)

    62,599       1,226,314  

Progyny, Inc.(a)(b)

    79,964       3,050,627  

Quipt Home Medical Corp.(a)(b)

    4,474       19,551  

RadNet, Inc.(a)

    12,009       584,358  

Select Medical Holdings Corp.

    33,868       1,021,120  

Surgery Partners, Inc.(a)

    45,634       1,361,262  
   

 

 

 
      20,853,274  
Health Care Technology — 0.6%            

Evolent Health, Inc., Class A(a)

    20,736       679,933  

Health Catalyst, Inc.(a)

    48,189       362,863  

HealthStream, Inc.

    17,378       463,298  

Phreesia, Inc.(a)

    47,160       1,128,539  

Schrodinger, Inc.(a)(b)

    1,317       35,559  

Teladoc Health, Inc.(a)

    76,021       1,147,917  
   

 

 

 
      3,818,109  
Hotel & Resort REITs — 0.3%            

RLJ Lodging Trust

    121,172       1,432,253  

Summit Hotel Properties, Inc.

    22,766       148,207  
   

 

 

 
      1,580,460  
Hotels, Restaurants & Leisure — 1.5%            

Accel Entertainment, Inc., Class A(a)

    39,210       462,286  

Boyd Gaming Corp.

    6,409       431,454  

Brinker International, Inc.(a)

    7,659       380,499  
 

 

 

S C H E D U L E O F I N V E S T M E N T S

  9


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Hotels, Restaurants & Leisure (continued)            

Chuy’s Holdings, Inc.(a)

    38,844     $ 1,310,208  

Everi Holdings, Inc.(a)

    116,703       1,172,865  

Hilton Grand Vacations, Inc.(a)

    2,251       106,270  

Life Time Group Holdings, Inc.(a)

    161       2,499  

Light & Wonder, Inc., Class A(a)

    11,589       1,183,121  

PlayAGS, Inc.(a)

    23,534       211,335  

Red Rock Resorts, Inc., Class A

    5,373       321,413  

Shake Shack, Inc., Class A(a)

    12,807       1,332,312  

Super Group SGHC Ltd.(a)

    77,790       268,376  

Wingstop, Inc.

    4,063       1,488,683  
   

 

 

 
      8,671,321  
Household Durables — 1.8%            

Century Communities, Inc.

    13,320       1,285,380  

Dream Finders Homes, Inc., Class A(a)

    432       18,891  

Installed Building Products, Inc.

    22,011       5,694,906  

LGI Homes, Inc.(a)

    1,395       162,336  

Lovesac Co. (The)(a)

    5,248       118,605  

Sonos, Inc.(a)

    17,141       326,708  

Toll Brothers, Inc.

    19,778       2,558,680  

TopBuild Corp.(a)

    145       63,906  

Tri Pointe Homes, Inc.(a)

    3,520       136,083  

Vizio Holding Corp., Class A(a)

    29,915       327,270  
   

 

 

 
       10,692,765  
Household Products — 0.1%            

WD-40 Co.

    1,691       428,347  
   

 

 

 
Independent Power and Renewable Electricity Producers — 0.1%  

Brookfield Renewable Corp., Class A

    19,630       482,309  
   

 

 

 
Industrial Conglomerates — 0.0%  

Brookfield Business Corp., Class A

    2,067       49,897  
   

 

 

 
Insurance — 0.9%  

Crawford & Co., Class A, NVS

    27,270       257,156  

Globe Life, Inc.

    1,540       179,210  

Investors Title Co.

    1       163  

Palomar Holdings, Inc.(a)

    16,843       1,411,949  

Reinsurance Group of America, Inc.

    4,950       954,756  

Selective Insurance Group, Inc.

    20,821       2,273,029  

Tiptree, Inc.

    11,358       196,266  
   

 

 

 
      5,272,529  
Interactive Media & Services — 1.4%            

Bumble, Inc., Class A(a)

    32,502       368,898  

Cargurus, Inc., Class A(a)

    53,431       1,233,188  

Cars.com, Inc.(a)

    29,108       500,075  

DHI Group, Inc.(a)

    23,984       61,159  

EverQuote, Inc., Class A(a)

    2,616       48,553  

MediaAlpha, Inc., Class A(a)

    10,520       214,292  

Outbrain, Inc.(a)

    5,592       22,088  

QuinStreet, Inc.(a)

    32,725       577,924  

Shutterstock, Inc.

    23,027       1,054,867  

Vimeo, Inc.(a)

    69,141       282,787  

Yelp, Inc.(a)

    61,915       2,439,451  

ZipRecruiter, Inc., Class A(a)

    115,711       1,329,519  
   

 

 

 
      8,132,801  
IT Services — 0.7%            

Backblaze, Inc., Class A(a)

    9,083       92,919  

Brightcove, Inc.(a)

    93,107       180,628  

Couchbase, Inc.(a)

    10,867       285,911  

DigitalOcean Holdings, Inc.(a)(b)

    8,129       310,365  

Fastly, Inc., Class A(a)

    53,373       692,248  

Grid Dynamics Holdings, Inc., Class A(a)

    16,884       207,504  
Security   Shares     Value  
IT Services (continued)            

Hackett Group, Inc. (The)

    15,029     $ 365,205  

Information Services Group, Inc.

    43,243       174,702  

Kyndryl Holdings, Inc.(a)

    18,187       395,749  

Squarespace, Inc., Class A(a)

    30,137       1,098,192  

Unisys Corp.(a)

    40,906       200,848  
   

 

 

 
      4,004,271  
Leisure Products — 0.3%            

Acushnet Holdings Corp.

    22,851       1,507,023  

Malibu Boats, Inc., Class A(a)

    11,474       496,595  
   

 

 

 
      2,003,618  
Life Sciences Tools & Services — 0.4%            

10X Genomics, Inc., Class A(a)

    6,723       252,314  

Codexis, Inc.(a)

    107,222       374,205  

Medpace Holdings, Inc.(a)

    1,607       649,469  

Pacific Biosciences of California, Inc.(a)

    153,199       574,496  

Personalis, Inc.(a)

    127,318       189,704  

Seer, Inc., Class A(a)

    139,315       264,699  
   

 

 

 
      2,304,887  
Machinery — 4.7%            

Alamo Group, Inc.

    7,069       1,614,065  

Albany International Corp., Class A

    1,638       153,169  

Blue Bird Corp.(a)

    15,005       575,292  

Chart Industries, Inc.(a)

    3,080       507,338  

Federal Signal Corp.

    11,303       959,286  

Flowserve Corp.

    122,459       5,593,927  

Franklin Electric Co., Inc.

    13,090       1,398,143  

Kadant, Inc.

    7,171       2,352,805  

Kennametal, Inc.

    45,217       1,127,712  

Manitowoc Co., Inc. (The)(a)

    54,012       763,730  

Miller Industries, Inc.

    83       4,158  

Mueller Industries, Inc.

    59,303       3,198,211  

Oshkosh Corp.

    28,065       3,499,986  

Shyft Group, Inc. (The)

    1,677       20,828  

SPX Technologies, Inc.(a)

    700       86,191  

Tennant Co.

    17,156       2,086,341  

Terex Corp.

    19,465       1,253,546  

Trinity Industries, Inc.

    8,490       236,447  

Watts Water Technologies, Inc., Class A

    10,950       2,327,422  

Xylem, Inc.

    2,376       307,074  
   

 

 

 
       28,065,671  
Media — 0.4%            

Integral Ad Science Holding Corp.(a)

    24,205       241,324  

Paramount Global, Class B, NVS

    71,733       844,298  

PubMatic, Inc., Class A(a)

    4,356       103,324  

TechTarget, Inc.(a)

    5,604       185,380  

Thryv Holdings, Inc.(a)

    36,164       803,926  
   

 

 

 
      2,178,252  
Metals & Mining — 1.4%            

Alcoa Corp.

    4,006       135,363  

Century Aluminum Co.(a)

    78,743       1,211,855  

Compass Minerals International, Inc.

    7,970       125,448  

Hecla Mining Co.

    9,344       44,945  

i-80 Gold Corp.(a)(b)

    218,295       292,515  

Kaiser Aluminum Corp.

    18,361       1,640,739  

Materion Corp.

    16,280       2,144,890  

NioCorp Developments Ltd.(a)(b)

    44,361       120,662  

Novagold Resources, Inc.(a)

    255,139       765,417  

Olympic Steel, Inc.

    12,645       896,277  

Perpetua Resources Corp.(a)

    12,840       53,414  

Radius Recycling, Inc., Class A

    7,845       165,765  
 

 

 

10  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Metals & Mining (continued)            

Ryerson Holding Corp.

    24,225     $ 811,537  

Tredegar Corp.

    8,182       53,347  
   

 

 

 
      8,462,174  
Multi-Utilities — 0.0%            

Black Hills Corp.

    251       13,705  
   

 

 

 
Office REITs — 0.1%  

Brandywine Realty Trust

    24,312       116,697  

Equity Commonwealth(a)

    17,727       334,686  

Paramount Group, Inc.

    3,427       16,073  
   

 

 

 
      467,456  
Oil, Gas & Consumable Fuels — 2.3%            

Ardmore Shipping Corp.

    8       131  

Delek U.S. Holdings, Inc.

    46,457       1,428,088  

DHT Holdings, Inc.

    4       46  

Energy Fuels, Inc.(a)(b)

    76,707       482,487  

HF Sinclair Corp.

    3,489       210,631  

Kosmos Energy Ltd.(a)

    750       4,470  

Magnolia Oil & Gas Corp., Class A

    154,810       4,017,319  

Matador Resources Co.

    14,958       998,746  

Murphy Oil Corp.

    17,371       793,855  

Par Pacific Holdings, Inc.(a)

    31,603       1,171,207  

PBF Energy, Inc., Class A

    35,863       2,064,633  

Plains GP Holdings LP, Class A

    12,934       236,046  

REX American Resources Corp.(a)

    19,305       1,133,397  

SM Energy Co.

    13,736       684,740  

World Kinect Corp.

    12,210       322,954  
   

 

 

 
       13,548,750  
Passenger Airlines — 0.2%            

Allegiant Travel Co.

    40       3,008  

Sun Country Airlines Holdings, Inc.(a)

    66,766       1,007,499  
   

 

 

 
      1,010,507  
Personal Care Products — 0.6%            

BellRing Brands, Inc.(a)

    6,594       389,244  

elf Beauty, Inc.(a)

    14,778       2,896,931  

USANA Health Sciences, Inc.(a)

    1,486       72,071  
   

 

 

 
      3,358,246  
Pharmaceuticals — 3.2%            

Alto Neuroscience, Inc.(a)

    110       1,689  

Amphastar Pharmaceuticals, Inc.(a)

    20,318       892,163  

Amylyx Pharmaceuticals, Inc.(a)

    34,822       98,894  

ANI Pharmaceuticals, Inc.(a)

    6,724       464,830  

Arvinas, Inc.(a)

    31,705       1,308,782  

Atea Pharmaceuticals, Inc.(a)

    219,178       885,479  

Axsome Therapeutics, Inc.(a)

    10,564       843,007  

Collegium Pharmaceutical, Inc.(a)(b)

    25,049       972,402  

Corcept Therapeutics, Inc.(a)(b)

    147,725       3,721,193  

Elanco Animal Health, Inc.(a)

    3,565       58,038  

Harmony Biosciences Holdings, Inc.(a)(b)

    37,536       1,260,459  

Intra-Cellular Therapies, Inc.(a)

    39,178       2,711,118  

Marinus Pharmaceuticals, Inc.(a)

    12,609       113,985  

Mind Medicine MindMed, Inc.(a)

    2,537       23,848  

Nuvation Bio, Inc., Class A(a)

    168,429       613,082  

Ocular Therapeutix, Inc.(a)

    1,795       16,335  

Pacira BioSciences, Inc.(a)

    51,585       1,507,314  

Phibro Animal Health Corp., Class A

    6,113       79,041  

Pliant Therapeutics, Inc.(a)

    4,456       66,394  

Prestige Consumer Healthcare, Inc.(a)

    17       1,234  

Scilex Holding Co.(a)(d)

    29,374       44,292  

SIGA Technologies, Inc.

    6,825       58,422  
Security   Shares     Value  
Pharmaceuticals (continued)            

Supernus Pharmaceuticals, Inc.(a)

    99,267     $ 3,385,997  

Xeris Biopharma Holdings, Inc.(a)

    59,644       131,813  
   

 

 

 
      19,259,811  
Professional Services — 3.6%            

Barrett Business Services, Inc.

    64       8,110  

CSG Systems International, Inc.

    6,871       354,131  

ExlService Holdings, Inc.(a)

    184,364       5,862,775  

Franklin Covey Co.(a)

    12,406       487,060  

Genpact Ltd.

    16,480       543,016  

Huron Consulting Group, Inc.(a)

    19,375       1,872,012  

Insperity, Inc.

    51,623       5,658,397  

KBR, Inc.

    3,641       231,786  

ManpowerGroup, Inc.

    20,570       1,597,055  

Maximus, Inc.

    37,654       3,159,171  

Parsons Corp.(a)

    17,511       1,452,537  

Upwork, Inc.(a)

    4,865       59,645  
   

 

 

 
       21,285,695  
Real Estate Management & Development — 0.2%  

Anywhere Real Estate, Inc.(a)

    55,524       343,138  

RMR Group, Inc. (The), Class A

    6       144  

St. Joe Co. (The)

    19,350       1,121,720  
   

 

 

 
      1,465,002  
Residential REITs — 0.1%            

NexPoint Residential Trust, Inc.

    12,840       413,320  
   

 

 

 
Semiconductors & Semiconductor Equipment — 3.9%  

ACM Research, Inc., Class A(a)

    13,074       380,976  

Ambarella, Inc.(a)

    12,674       643,459  

Amkor Technology, Inc.

    20,045       646,251  

Astera Labs, Inc.(a)

    6,368       472,442  

Axcelis Technologies, Inc.(a)(b)

    36,063       4,021,746  

Credo Technology Group Holding Ltd.(a)

    86,929       1,842,025  

Diodes, Inc.(a)

    43,262       3,049,971  

FormFactor, Inc.(a)

    2,846       129,863  

Impinj, Inc.(a)

    3,526       452,774  

Maxeon Solar Technologies Ltd.(a)

    185,642       618,188  

MaxLinear, Inc.(a)

    78,876       1,472,615  

Onto Innovation, Inc.(a)

    10,464       1,894,821  

Photronics, Inc.(a)

    5,490       155,477  

Power Integrations, Inc.(b)

    37,077       2,652,859  

Rambus, Inc.(a)

    34,405       2,126,573  

Silicon Laboratories, Inc.(a)

    11,250       1,616,850  

SiTime Corp.(a)

    9,397       876,082  

SMART Global Holdings, Inc.(a)

    15,105       397,564  
   

 

 

 
      23,450,536  
Software — 11.9%            

8x8, Inc.(a)

    177,347       478,837  

ACI Worldwide, Inc.(a)

    126,085       4,187,283  

Agilysys, Inc.(a)

    7,925       667,760  

Alarm.com Holdings, Inc.(a)

    20,004       1,449,690  

Alkami Technology, Inc.(a)

    10,576       259,852  

Altair Engineering, Inc., Class A(a)

    19,190       1,653,218  

Amplitude, Inc., Class A(a)

    36,947       401,983  

Appfolio, Inc., Class A(a)

    9,235       2,278,644  

Appian Corp., Class A(a)

    2,903       115,975  

Bit Digital, Inc.(a)(b)

    236,804       679,627  

Blackbaud, Inc.(a)

    14,368       1,065,244  

BlackLine, Inc.(a)

    13,231       854,458  

Box, Inc., Class A(a)

    49,627       1,405,437  

Braze, Inc., Class A(a)

    30,517       1,351,903  

C3.ai, Inc., Class A(a)

    9,267       250,858  
 

 

 

S C H E D U L E O F I N V E S T M E N T S

  11


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Software (continued)            

Clear Secure, Inc., Class A

    86,813     $ 1,846,513  

CommVault Systems, Inc.(a)

    36,654       3,717,815  

Confluent, Inc., Class A(a)

    29,769       908,550  

DocuSign, Inc.(a)

    727       43,293  

Domo, Inc., Class B(a)

    14,144       126,164  

eGain Corp.(a)

    5,397       34,811  

Elastic NV(a)

    612       61,347  

Everbridge, Inc.(a)

    17,980       626,243  

Expensify, Inc., Class A(a)

    31,931       58,753  

Five9, Inc.(a)

    13,000       807,430  

Freshworks, Inc., Class A(a)

    82,579       1,503,764  

Gitlab, Inc., Class A(a)

    19,828       1,156,369  

Informatica, Inc., Class A(a)

    11,110       388,850  

Intapp, Inc.(a)

    23,339       800,528  

InterDigital, Inc.

    2,431       258,804  

Jamf Holding Corp.(a)

    2,215       40,645  

Marathon Digital Holdings, Inc.(a)

    48,726       1,100,233  

MicroStrategy, Inc., Class A(a)

    6,053       10,317,702  

Model N, Inc.(a)(b)

    46,506       1,324,026  

N-able, Inc.(a)

    30,735       401,706  

Nutanix, Inc., Class A(a)

    14,316       883,584  

Olo, Inc., Class A(a)

    37,360       205,106  

Pegasystems, Inc.

    3,027       195,665  

PROS Holdings, Inc.(a)

    5,561       202,031  

Q2 Holdings, Inc.(a)

    57,761       3,035,918  

Qualys, Inc.(a)

    15,029       2,507,889  

Rapid7, Inc.(a)

    24,752       1,213,838  

Red Violet, Inc.(a)

    937       18,318  

RingCentral, Inc., Class A(a)

    8,094       281,186  

SEMrush Holdings, Inc., Class A(a)

    112,652       1,493,766  

SentinelOne, Inc., Class A(a)

    34,652       807,738  

Sprinklr, Inc., Class A(a)

    73,341       899,894  

Sprout Social, Inc., Class A(a)(b)

    19,751       1,179,332  

SPS Commerce, Inc.(a)

    6,094       1,126,781  

Tenable Holdings, Inc.(a)

    36,181       1,788,427  

Teradata Corp.(a)

    9,004       348,185  

Upland Software, Inc.(a)

    2,625       8,111  

Varonis Systems, Inc.(a)

    87,122       4,109,545  

Verint Systems, Inc.(a)

    38,785       1,285,723  

Weave Communications, Inc.(a)

    36,348       417,275  

Workiva, Inc., Class A(a)

    24,998       2,119,830  

Yext, Inc.(a)

    27,969       168,653  

Zeta Global Holdings Corp., Class A(a)

    165,513       1,809,057  

Zuora, Inc., Class A(a)

    187,127       1,706,598  
   

 

 

 
       70,436,765  
Specialized REITs — 0.0%            

Outfront Media, Inc.

    2,286       38,382  
   

 

 

 
Specialty Retail — 2.9%            

1-800-Flowers.com, Inc., Class A(a)

    57,758       625,519  

Aaron’s Co., Inc. (The)

    51,736       388,020  

Abercrombie & Fitch Co., Class A(a)

    18,908       2,369,740  

Academy Sports & Outdoors, Inc.

    26,619       1,797,847  

American Eagle Outfitters, Inc.

    4,473       115,359  

Arhaus, Inc., Class A

    664       10,219  

Arko Corp., Class A

    22,658       129,151  

CarParts.com, Inc.(a)

    270,640       438,437  

Carvana Co., Class A(a)

    17,484       1,537,018  

Chewy, Inc., Class A(a)

    39,204       623,736  

Duluth Holdings, Inc., Class B(a)

    34,202       167,590  

Five Below, Inc.(a)

    36       6,530  

Genesco, Inc.(a)

    376       10,581  

Group 1 Automotive, Inc.

    5,901       1,724,449  
Security   Shares     Value  
Specialty Retail (continued)            

Haverty Furniture Cos., Inc.

    5     $ 171  

Lands’ End, Inc.(a)

    8,105       88,263  

Murphy U.S.A., Inc.

    67       28,086  

National Vision Holdings, Inc.(a)

    7,765       172,072  

Penske Automotive Group, Inc.

    2,781       450,494  

Revolve Group, Inc., Class A(a)(b)

    19,415       411,016  

Stitch Fix, Inc., Class A(a)

    178,846       472,153  

Upbound Group, Inc.

    53,089       1,869,264  

Urban Outfitters, Inc.(a)

    3,047       132,301  

Warby Parker, Inc., Class A(a)

    75,321       1,025,119  

Wayfair, Inc., Class A(a)

    18,296       1,241,932  

Winmark Corp.

    3,219       1,164,312  

Zumiez, Inc.(a)

    36,192       549,756  
   

 

 

 
      17,549,135  
Technology Hardware, Storage & Peripherals — 3.7%  

Super Micro Computer, Inc.(a)

    21,962       22,182,279  
   

 

 

 
Textiles, Apparel & Luxury Goods — 0.7%            

Figs, Inc., Class A(a)

    104,651       521,162  

G-III Apparel Group Ltd.(a)

    33,810       980,828  

Kontoor Brands, Inc.

    6,440       388,010  

Ralph Lauren Corp., Class A

    10,926       2,051,466  
   

 

 

 
      3,941,466  
Trading Companies & Distributors — 3.3%  

Applied Industrial Technologies, Inc.

    16,319       3,223,819  

Beacon Roofing Supply, Inc.(a)

    5,468       535,973  

BlueLinx Holdings, Inc.(a)

    6,078       791,599  

Boise Cascade Co.

    24,238       3,717,382  

DNOW, Inc.(a)

    35,256       535,891  

FTAI Aviation Ltd.

    15,159       1,020,201  

GATX Corp.

    5,379       720,947  

Global Industrial Co.

    17,371       777,873  

GMS, Inc.(a)

    37,450       3,645,383  

H&E Equipment Services, Inc.

    8,706       558,751  

Herc Holdings, Inc.

    12,869       2,165,853  

McGrath RentCorp.

    10,559       1,302,664  

MRC Global, Inc.(a)

    36,455       458,239  
   

 

 

 
      19,454,575  
   

 

 

 

Total Common Stocks — 98.6%
(Cost: $469,327,839)

       584,683,219  
   

 

 

 

Preferred Securities

   

Preferred Stocks — 0.5%

   
Software — 0.5%            

Illumio, Inc., Series C(a)(c)(d)

    311,155       3,260,904  
   

 

 

 
Technology Hardware, Storage & Peripherals — 0.0%  

AliphCom

   

Series 6, (a)(c)(d)

    8,264        

Series 8, (a)(c)

    192,156       2  
   

 

 

 
      2  
   

 

 

 

Total Preferred Securities — 0.5%
(Cost: $2,175,301)

      3,260,906  
   

 

 

 

Rights

   

Biotechnology — 0.0%

   

Aduro Biotech, Inc., CVR(a)(c)

    18,964       9,482  

Albireo Pharma Inc., CVR(a)(c)

    7,975       25,998  
 

 

 

12  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Biotechnology (continued)            

Flexion Therapeutics, Inc., CVR(a)(c)

    33,053     $ 17,849  

Prevail Therapeutics, Inc., CVR(a)(c)

    10,004       5,002  
   

 

 

 
      58,331  
Metals & Mining — 0.0%            

Pan American Silver Corp., CVR(a)

    36,363       16,291  
   

 

 

 

Total Rights — 0.0%
(Cost: $—)

      74,622  
   

 

 

 

Total Long-Term Investments — 99.1%
(Cost: $471,503,140)

      588,018,747  
   

 

 

 

Short-Term Securities

   

Money Market Funds — 4.1%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 5.50%(e)(f)(g)

    18,492,985       18,500,382  

BlackRock Liquidity Funds, T-Fund, Institutional Class, 5.19%(e)(f)

    5,795,096       5,795,096  
   

 

 

 

Total Short-Term Securities — 4.1%
(Cost: $24,295,478)

      24,295,478  
   

 

 

 

Total Investments — 103.2%
(Cost: $495,798,618)

      612,314,225  

Liabilities in Excess of Other Assets — (3.2)%

 

    (19,188,844
   

 

 

 

Net Assets — 100.0%

    $  593,125,381  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d) 

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $3,305,196, representing 0.6% of its net assets as of period end, and an original cost of $1,349,355.

(e) 

Affiliate of the Fund.

(f) 

Annualized 7-day yield as of period end.

(g) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended March 31, 2024 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
09/30/23
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
    Value at
03/31/24
    Shares
Held at
03/31/24
    Income     Capital
Gain
Distributions
from Underlying
Funds
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $     $ 18,499,402 (a)    $     $ 980      $     $ 18,500,382       18,492,985     $ 1,546 (b)     $  

BlackRock Liquidity Funds, T-Fund, Institutional Class

    4,598,231       1,196,865 (a)                          5,795,096       5,795,096       133,418        

SL Liquidity Series, LLC, Money Market Series(c)

    19,015,072             (19,013,101 )(a)      14,354        (16,325                 45,311 (b)        
       

 

 

    

 

 

   

 

 

     

 

 

   

 

 

 
        $ 15,334      $ (16,325   $ 24,295,478       $ 180,275     $  
       

 

 

    

 

 

   

 

 

     

 

 

   

 

 

 

 

(a) 

Represents net amount purchased (sold).

(b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

(c) 

As of period end, the entity is no longer held.

For purposes of this report, industry and sector sub-classifications may differ from those utilized by the Fund for compliance purposes.

 

 

S C H E D U L E O F I N V E S T M E N T S

  13


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 
Description    Number of
Contracts
       Expiration
Date
       Notional
Amount
(000)
       Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

                 

Russell 2000 E-Mini Index

     57          06/21/24        $ 6,116        $ 151,219  
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statement of Assets and Liabilities were as follows:

 

               
      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Assets — Derivative Financial Instruments

                    

Futures contracts

                    

Unrealized appreciation on futures contracts(a)

   $      $—        $  151,219      $      $      $      $  151,219  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts, if any, are reported in the Schedule of Investments. In the Statement of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2024, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

               
      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Net Realized Gain (Loss) from:

                    

Futures contracts

   $      $      $  679,346      $      $      $      $  679,346  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

                    

Futures contracts

   $      $      $ 295,587      $      $      $      $ 295,587  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

   

Futures contracts

  

Average notional value of contracts — long

     $ 6,231,843  

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 2,305,186        $        $        $ 2,305,186  

Air Freight & Logistics

     119,992                            119,992  

Automobile Components

      12,939,924           —           —           12,939,924  

Banks

     1,025,583                            1,025,583  

Beverages

     4,708,475                            4,708,475  

Biotechnology

     65,436,570                   3,207          65,439,777  

Broadline Retail

     1,213,494                            1,213,494  

 

 

14  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

 

Fair Value Hierarchy as of Period End (continued)

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Common Stocks (continued)

                 

Building Products

   $ 14,239,606        $        $        $ 14,239,606  

Capital Markets

     6,034,623                            6,034,623  

Chemicals

     11,145,554                            11,145,554  

Commercial Services & Supplies

     2,196,175                            2,196,175  

Communications Equipment

     3,445,411                            3,445,411  

Construction & Engineering

     23,769,002                            23,769,002  

Consumer Finance

     7,309,322                            7,309,322  

Consumer Staples Distribution & Retail

     2,208,220                            2,208,220  

Diversified Consumer Services

     13,569,654                            13,569,654  

Diversified Telecommunication Services

     1,915,292                            1,915,292  

Electric Utilities

     1,339,419                            1,339,419  

Electrical Equipment

     13,481,067                            13,481,067  

Electronic Equipment, Instruments & Components

     24,627,938                            24,627,938  

Energy Equipment & Services

     4,813,969                            4,813,969  

Entertainment

     1,201,401                            1,201,401  

Financial Services

     9,855,482                            9,855,482  

Food Products

     9,307,679                            9,307,679  

Gas Utilities

     913,224                            913,224  

Ground Transportation

     69,397                            69,397  

Health Care Equipment & Supplies

     20,612,038                            20,612,038  

Health Care Providers & Services

     20,853,274                            20,853,274  

Health Care Technology

     3,818,109                            3,818,109  

Hotel & Resort REITs

     1,580,460                            1,580,460  

Hotels, Restaurants & Leisure

     8,671,321                            8,671,321  

Household Durables

     10,692,765                            10,692,765  

Household Products

     428,347                            428,347  

Independent Power and Renewable Electricity Producers

     482,309                            482,309  

Industrial Conglomerates

     49,897                            49,897  

Insurance

     5,272,529                            5,272,529  

Interactive Media & Services

     8,132,801                            8,132,801  

IT Services

     4,004,271                            4,004,271  

Leisure Products

     2,003,618                            2,003,618  

Life Sciences Tools & Services

     2,304,887                            2,304,887  

Machinery

     28,065,671                            28,065,671  

Media

     2,178,252                            2,178,252  

Metals & Mining

     8,462,174                            8,462,174  

Multi-Utilities

     13,705                            13,705  

Office REITs

     467,456                            467,456  

Oil, Gas & Consumable Fuels

     13,548,750                            13,548,750  

Passenger Airlines

     1,010,507                            1,010,507  

Personal Care Products

     3,358,246                            3,358,246  

Pharmaceuticals

     19,215,519          44,292                   19,259,811  

Professional Services

     21,285,695                            21,285,695  

Real Estate Management & Development

     1,465,002                            1,465,002  

Residential REITs

     413,320                            413,320  

Semiconductors & Semiconductor Equipment

     23,450,536                            23,450,536  

Software

     70,436,765                            70,436,765  

Specialized REITs

     38,382                            38,382  

Specialty Retail

     17,549,135                            17,549,135  

Technology Hardware, Storage & Peripherals

     22,182,279                            22,182,279  

Textiles, Apparel & Luxury Goods

     3,941,466                            3,941,466  

Trading Companies & Distributors

     19,454,575                            19,454,575  

Preferred Securities

                       3,260,906          3,260,906  

Rights

     16,291                   58,331          74,622  

Short-Term Securities

                 

Money Market Funds

     24,295,478                            24,295,478  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  608,947,489        $  44,292        $  3,322,444        $  612,314,225  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

 

S C H E D U L E O F I N V E S T M E N T S

  15


Schedule of Investments (unaudited) (continued)

March 31, 2024

  

BlackRock Advantage Small Cap Growth Fund

 

Fair Value Hierarchy as of Period End (continued)

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Derivative Financial Instruments(a)

                 

Assets

                 

Equity Contracts

   $  151,219        $  —        $  —        $  151,219  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

16  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


 

Statement of Assets and Liabilities (unaudited)

March 31, 2024

 

     BlackRock
Advantage
Small Cap
Growth Fund
 

ASSETS

 

Investments, at value — unaffiliated(a)(b)

  $ 588,018,747  

Investments, at value — affiliated(c)

    24,295,478  

Cash

    595,253  

Cash pledged:

 

Futures contracts

    375,000  

Foreign currency, at value(d)

    12,852  

Receivables:

 

Investments sold

    6,133,599  

Securities lending income — affiliated

    13,087  

Capital shares sold

    675,882  

Dividends — unaffiliated

    215,397  

Dividends — affiliated

    24,774  

From the Manager

    60,118  

Prepaid expenses

    52,845  
 

 

 

 

Total assets

    620,473,032  
 

 

 

 

LIABILITIES

 

Collateral on securities loaned

    18,499,401  

Payables:

 

Investments purchased

    6,791,150  

Administration fees

    20,756  

Capital shares redeemed

    1,460,066  

Investment advisory fees

    150,491  

Trustees’ and Officer’s fees

    2,401  

Other accrued expenses

    366,049  

Other affiliate fees

    5,283  

Professional fees

    14,962  

Service and distribution fees

    37,092  
 

 

 

 

Total liabilities

    27,347,651  
 

 

 

 

Commitments and contingent liabilities

 

NET ASSETS

  $ 593,125,381  
 

 

 

 

NET ASSETS CONSIST OF:

 

Paid-in capital

  $ 577,754,128  

Accumulated earnings

    15,371,253  
 

 

 

 

NET ASSETS

  $  593,125,381  
 

 

 

 

(a) Investments, at cost — unaffiliated

  $ 471,503,140  

(b) Securities loaned, at value

  $ 18,198,773  

(c)  Investments, at cost — affiliated

  $ 24,295,478  

(d) Foreign currency, at cost

  $ 12,418  

 

 

F I N A N C I A L S T A T E M E N T S

  17


 

Statement of Assets and Liabilities (unaudited) (continued)

March 31, 2024

 

           

BlackRock
Advantage

Small Cap

Growth Fund

      

NET ASSET VALUE

         
Institutional                

Net assets

    $ 375,054,071    
   

 

 

   

Shares outstanding

      18,403,837    
   

 

 

   

Net asset value

    $ 20.38    
   

 

 

   

Shares authorized

      Unlimited    
   

 

 

   

Par value

    $ 0.001    
   

 

 

   
Investor A                

Net assets

    $  161,422,852    
   

 

 

   

Shares outstanding

      12,589,237    
   

 

 

   

Net asset value

    $ 12.82    
   

 

 

   

Shares authorized

      Unlimited    
   

 

 

   

Par value

    $ 0.001    
   

 

 

   
Class K                

Net assets

    $ 48,645,264    
   

 

 

   

Shares outstanding

      2,387,257    
   

 

 

   

Net asset value

    $ 20.38    
   

 

 

   

Shares authorized

      Unlimited    
   

 

 

   

Par value

    $ 0.001    
   

 

 

   
Class R                

Net assets

    $ 8,003,194    
   

 

 

   

Shares outstanding

      623,296    
   

 

 

   

Net asset value

    $ 12.84    
   

 

 

   

Shares authorized

      Unlimited    
   

 

 

   

Par value

    $ 0.001    
   

 

 

   

See notes to financial statements.

 

 

18  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


 

Statement of Operations (unaudited)

Six Months Ended March 31, 2024

 

            BlackRock
Advantage
Small Cap
Growth Fund
        

INVESTMENT INCOME

         

Dividends — unaffiliated

    $ 1,949,596    

Dividends — affiliated

      133,418    

Securities lending income — affiliated — net

      46,857    

Foreign taxes withheld

      (2,204  
   

 

 

   

Total investment income

      2,127,667    
   

 

 

   

EXPENSES

     

Investment advisory

      1,198,931    

Transfer agent — class specific

      457,875    

Service and distribution — class specific

      206,665    

Administration

      112,758    

Custodian

      80,709    

Administration — class specific

      53,295    

Professional

      48,296    

Registration

      37,671    

Accounting services

      32,683    

Printing and postage

      18,766    

Trustees and Officer

      4,470    

Miscellaneous

      21,968    
   

 

 

   

Total expenses

      2,274,087    

Less:

     

Administration fees waived by the Manager — class specific

      (53,296  

Fees waived and/or reimbursed by the Manager

      (357,271  

Transfer agent fees waived and/or reimbursed by the Manager — class specific

      (335,846  
   

 

 

   

Total expenses after fees waived and/or reimbursed

      1,527,674    
   

 

 

   

Net investment income

      599,993    
   

 

 

   

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain from:

     

Investments — unaffiliated

      18,309,567    

Investments — affiliated

      15,334    

Futures contracts

      679,346    
   

 

 

   
      19,004,247    
   

 

 

   

Net change in unrealized appreciation (depreciation) on:

     

Investments — unaffiliated

      93,996,544    

Investments — affiliated

      (16,325  

Futures contracts

      295,587    

Foreign currency translations

      427    
   

 

 

   
      94,276,233    
   

 

 

   

Net realized and unrealized gain

      113,280,480    
   

 

 

   

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

    $  113,880,473    
   

 

 

   

See notes to financial statements.

 

 

F I N A N C I A L S T A T E M E N T S

  19


 

Statements of Changes in Net Assets

 

    BlackRock Advantage Small Cap Growth Fund      
 

 

 

   
    Six Months
Ended
                
    03/31/24          Year Ended      
     (unaudited)           09/30/23       

INCREASE (DECREASE) IN NET ASSETS

        

OPERATIONS

        

Net investment income

  $ 599,993        $ 818,535    

Net realized gain (loss)

    19,004,247          (4,264,717  

Net change in unrealized appreciation (depreciation)

    94,276,233          56,948,937    
 

 

 

      

 

 

   

Net increase in net assets resulting from operations

    113,880,473          53,502,755    
 

 

 

      

 

 

   

DISTRIBUTIONS TO SHAREHOLDERS(a)

        

Institutional

    (857,268        (1,469,010  

Investor A

    (288,412        (805,964  

Class K

    (132,904        (196,279  

Class R

             (16,243  
 

 

 

      

 

 

   

Decrease in net assets resulting from distributions to shareholders

    (1,278,584        (2,487,496  
 

 

 

      

 

 

   

CAPITAL SHARE TRANSACTIONS

        

Net decrease in net assets derived from capital share transactions

    (18,528,538        (42,496,028  
 

 

 

      

 

 

   

NET ASSETS

        

Total increase in net assets

    94,073,351          8,519,231    

Beginning of period

    499,052,030          490,532,799    
 

 

 

      

 

 

   

End of period

  $ 593,125,381        $ 499,052,030    
 

 

 

      

 

 

   

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

20  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Advantage Small Cap Growth Fund  
    Institutional  
    Six Months
Ended
03/31/24
(unaudited)
    Year Ended
09/30/23
     Year Ended
09/30/22
     Year Ended
09/30/21
     Year Ended
09/30/20
     Year Ended
09/30/19
 
             

Net asset value, beginning of period

  $ 16.58     $ 15.04      $ 25.11      $ 19.86      $ 18.01      $ 23.65  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income(a)

    0.03       0.04        0.04        0.01        0.05        0.07  

Net realized and unrealized gain (loss)

    3.82       1.57        (6.20      6.54        2.84        (2.03
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    3.85       1.61        (6.16      6.55        2.89        (1.96
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Distributions(b)

               

From net investment income

    (0.05     (0.07             (0.01      (0.07      (0.05

From net realized gain

                 (3.91      (1.29      (0.97      (3.63
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total distributions

    (0.05     (0.07      (3.91      (1.30      (1.04      (3.68
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 20.38     $ 16.58      $ 15.04      $ 25.11      $ 19.86      $ 18.01  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

               

Based on net asset value

    23.25 %(d)      10.72      (29.20 )%       33.89      16.32      (6.80 )% 
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(e)

               

Total expenses

    0.78 %(f)       0.82      0.71      0.68      0.73      0.74
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.50 %(f)       0.50      0.50      0.50      0.50      0.50
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income

    0.29 %(f)       0.23      0.22      0.04      0.25      0.40
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $ 375,054     $ 304,607      $ 300,391      $ 743,578      $ 508,084      $ 396,388  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    64     133      102      125      126      120
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

See notes to financial statements.

 

 

F I N A N C I A L H I G H L I G H T S 

  21


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock Advantage Small Cap Growth Fund (continued)  
    Investor A  
    Six Months
Ended
03/31/24
(unaudited)
    Year Ended
09/30/23
     Year Ended
09/30/22
     Year Ended
09/30/21
     Year Ended
09/30/20
    Year Ended
09/30/19
 
             

Net asset value, beginning of period

  $ 10.43     $ 9.50      $ 17.27      $ 14.01      $ 12.98     $ 18.25  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Net investment income (loss)(a)

    0.00 (b)       (0.00 )(c)        0.00 (b)        (0.04      0.00 (b)       0.02  

Net realized and unrealized gain (loss)

    2.41       0.98        (3.90      4.57        2.04       (1.65
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    2.41       0.98        (3.90      4.53        2.04       (1.63
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Distributions(d)

              

From net investment income

    (0.02     (0.05                    (0.04     (0.01

From net realized gain

                 (3.87      (1.27      (0.97     (3.63
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total distributions

    (0.02     (0.05      (3.87      (1.27      (1.01     (3.64
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 12.82     $ 10.43      $ 9.50      $ 17.27      $ 14.01     $ 12.98  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(e)

              

Based on net asset value

    23.15 %(f)      10.32      (29.32 )%       33.54      16.03     (7.05 )% 
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(g)

              

Total expenses

    1.05 %(h)       1.06      0.97      0.96      1.02     1.00
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.75 %(h)       0.75      0.75      0.75      0.75     0.75
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Net investment income (loss)

    0.06 %(h)       (0.02 )%       0.01      (0.21 )%       0.00 %(i)       0.15
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

              

Net assets, end of period (000)

  $ 161,423     $ 148,563      $ 149,192      $ 225,211      $ 168,457     $ 178,847  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    64     133      102      125      126     120
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Amount is less than $0.005 per share.

(c)

Amount is greater than $(0.005) per share.

(d)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e)

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f)

Not annualized.

(g)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h)

Annualized.

(i)

Amount is less than 0.005%.

See notes to financial statements.

 

 

22  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock Advantage Small Cap Growth Fund (continued)  
    Class K  
    Six Months
Ended
03/31/24
(unaudited)
    Year Ended
09/30/23
     Year Ended
09/30/22
     Year Ended
09/30/21
     Year Ended
09/30/20
     Year Ended
09/30/19
 
             

Net asset value, beginning of period

  $ 16.58     $ 15.05      $ 25.11      $ 19.86      $ 18.01      $ 23.65  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income(a)

    0.03       0.05        0.06        0.02        0.05        0.09  

Net realized and unrealized gain (loss)

    3.83       1.57        (6.20      6.54        2.85        (2.04
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    3.86       1.62        (6.14      6.56        2.90        (1.95
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Distributions(b)

               

From net investment income

    (0.06     (0.09             (0.02      (0.08      (0.06

From net realized gain

                 (3.92      (1.29      (0.97      (3.63
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total distributions

    (0.06     (0.09      (3.92      (1.31      (1.05      (3.69
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 20.38     $ 16.58      $ 15.05      $ 25.11      $ 19.86      $ 18.01  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

               

Based on net asset value

    23.31 %(d)      10.72      (29.12 )%       33.94      16.37      (6.75 )% 
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(e)

               

Total expenses

    0.64 %(f)      0.65      0.57      0.56      0.58      0.60
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.45 %(f)      0.45      0.45      0.45      0.45      0.45
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income

    0.34 %(f)      0.28      0.33      0.08      0.27      0.52
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $ 48,645     $ 38,981      $ 34,153      $ 36,442      $ 13,264      $ 5,131  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    64     133      102      125      126      120
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d)

Not annualized.

(e)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Annualized.

See notes to financial statements.

 

 

F I N A N C I A L H I G H L I G H T S 

  23


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock Advantage Small Cap Growth Fund (continued)  
    Class R  
    Six Months
Ended
03/31/24
(unaudited)
    Year Ended
09/30/23
     Year Ended
09/30/22
     Year Ended
09/30/21
     Year Ended
09/30/20
     Year Ended
09/30/19
 
             

Net asset value, beginning of period

  $ 10.44     $ 9.50      $ 17.26      $ 13.99      $ 12.96      $ 18.22  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.01     (0.03      (0.03      (0.08      (0.03      (0.01

Net realized and unrealized gain (loss)

    2.41       0.99        (3.92      4.57        2.03        (1.64
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    2.40       0.96        (3.95      4.49        2.00        (1.65
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Distributions(b)

               

From net investment income

          (0.02                            

From net realized gain

                 (3.81      (1.22      (0.97      (3.61
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total distributions

          (0.02      (3.81      (1.22      (0.97      (3.61
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 12.84     $ 10.44      $ 9.50      $ 17.26      $ 13.99      $ 12.96  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

               

Based on net asset value

    22.99 %(d)      10.14      (29.57 )%       33.25      15.75      (7.27 )% 
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(e)

               

Total expenses

    1.33 %(f)      1.35      1.29      1.26      1.27      1.30
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.00 %(f)      1.00      1.00      1.00      1.00      1.00
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss

    (0.19 )%(f)      (0.27 )%       (0.25 )%       (0.45 )%       (0.24 )%       (0.10 )% 
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $ 8,003     $ 6,901      $ 6,797      $ 11,713      $ 11,314      $ 16,019  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    64     133      102      125      126      120
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d)

Not annualized.

(e)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Annualized.

See notes to financial statements.

 

 

24  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Notes to Financial Statements (unaudited)

 

1.

ORGANIZATION

BlackRock FundsSM (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Massachusetts business trust. BlackRock Advantage Small Cap Growth Fund (the “Fund”) is a series of the Trust. The Fund is classified as diversified.

The Fund offers multiple classes of shares. All classes of shares have identical voting, dividend, liquidation and other rights and are subject to the same terms and conditions, except that certain classes bear expenses related to the shareholder servicing and distribution of such shares. Institutional and Class K Shares are sold only to certain eligible investors. Investor A and Class R Shares bear certain expenses related to shareholder servicing of such shares, and Class R Shares also bear certain expenses related to the distribution of such shares. Investor A Shares are generally available through financial intermediaries. Class R Shares are sold only to certain employer-sponsored retirement plans. Each class has exclusive voting rights with respect to matters relating to its shareholder servicing and distribution expenditures.

 

Share Class   Initial Sales Charge      CDSC      Conversion Privilege

Institutional, Class K and Class R Shares

    No        No      None

Investor A Shares

    Yes        No (a)     None

 

  (a) 

Investor A Shares may be subject to a contingent deferred sales charge (“CDSC”) for certain redemptions where no initial sales charge was paid at the time of purchase.

The Fund, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the “Manager”) or its affiliates, is included in a complex of funds referred to as the BlackRock Multi-Asset Complex.

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. The Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend dates. Non-cash dividends, if any, are recorded on the ex-dividend dates at fair value. Dividends from foreign securities where the ex-dividend dates may have passed are subsequently recorded when the Fund is informed of the ex-dividend dates. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain. Income, expenses and realized and unrealized gains and losses are allocated daily to each class based on its relative net assets.

Foreign Currency Translation: The Fund’s books and records are maintained in U.S. dollars. Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the New York Stock Exchange (“NYSE”). Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.

The Fund does not isolate the effect of fluctuations in foreign exchange rates from the effect of fluctuations in the market prices of investments for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statement of Operations from the effects of changes in market prices of those investments, but are included as a component of net realized and unrealized gain (loss) from investments. The Fund reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for U.S. federal income tax purposes.

Foreign Taxes: The Fund may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which the Fund invests. These foreign taxes, if any, are paid by the Fund and are reflected in its Statement of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Foreign taxes withheld”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of March 31, 2024, if any, are disclosed in the Statement of Assets and Liabilities.

The Fund files withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Fund may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statement of Operations includes tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.

Collateralization: If required by an exchange or counterparty agreement, the Fund may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments.

Distributions: Distributions paid by the Fund are recorded on the ex-dividend dates. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

 

 

N O T E S T O F I N A N C I A L S T A T E M E N T S

  25


Notes to Financial Statements (unaudited) (continued)

 

Indemnifications: In the normal course of business, the Fund enters into contracts that contain a variety of representations that provide general indemnification. The Fund’s maximum exposure under these arrangements is unknown because it involves future potential claims against the Fund, which cannot be predicted with any certainty.

Other: Expenses directly related to the Fund or its classes are charged to the Fund or the applicable class. Expenses directly related to the Fund and other shared expenses prorated to the Fund are allocated daily to each class based on its relative net assets or other appropriate methods. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.

The Fund has an arrangement with its custodian whereby credits are earned on uninvested cash balances. For financial reporting purposes, custodian credits, if any, are included in interest income in the Statement of Operations.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: The Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund is open for business and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Board of Trustees of the Trust (the “Board”) has approved the designation of the Fund’s Manager as the valuation designee for the Fund. The Fund determines the fair values of its financial instruments using various independent dealers or pricing services under the Manager’s policies. If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with the Manager’s policies and procedures as reflecting fair value. The Manager has formed a committee (the “Valuation Committee”) to develop pricing policies and procedures and to oversee the pricing function for all financial instruments, with assistance from other BlackRock pricing committees.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of the Fund’s assets and liabilities:

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published net asset value (“NAV”).

 

   

Futures contracts are valued based on that day’s last reported settlement or trade price on the exchange where the contract is traded.

Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Each business day, the Fund uses current market factors supplied by independent pricing services to value certain foreign instruments (“Systematic Fair Value Price”). The Systematic Fair Value Price is designed to value such foreign securities at fair value as of the close of trading on the NYSE, which follows the close of the local markets.

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Valuation Committee in accordance with the Manager’s policies and procedures as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Valuation Committee seeks to determine the price that the Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Valuation Committee deems relevant and consistent with the principles of fair value measurement.

For investments in equity or debt issued by privately held companies or funds (“Private Company” or collectively, the “Private Companies”) and other Fair Valued Investments, the fair valuation approaches that are used by the Valuation Committee and third-party pricing services utilized by the Valuation Committee include one or a combination of, but not limited to, the following inputs.

 

Standard Inputs Generally Considered By The Valuation Committee And Third-Party Pricing Services

Market approach

 

(i)  recent market transactions, including subsequent rounds of financing, in the underlying investment or comparable issuers;

(ii) recapitalizations and other transactions across the capital structure; and

(iii)   market multiples of comparable issuers.

Income approach

 

(i)  future cash flows discounted to present and adjusted as appropriate for liquidity, credit, and/or market risks;

(ii) quoted prices for similar investments or assets in active markets; and

(iii)   other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default rates.

Cost approach

 

(i)  audited or unaudited financial statements, investor communications and financial or operational metrics issued by the Private Company;

(ii) changes in the valuation of relevant indices or publicly traded companies comparable to the Private Company;

(iii)   relevant news and other public sources; and

(iv)   known secondary market transactions in the Private Company’s interests and merger or acquisition activity in companies comparable to the Private Company.

Investments in series of preferred stock issued by Private Companies are typically valued utilizing market approach in determining the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Enterprise valuation techniques such as an option pricing model (“OPM”), a probability weighted expected return model (“PWERM”), current value method or a hybrid of those techniques are used as deemed appropriate

 

 

26  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

under the circumstances. The use of these valuation techniques involves a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.

The Private Companies are not subject to the public company disclosure, timing, and reporting standards applicable to other investments held by the Fund. Typically, the most recently available information by a Private Company is as of a date that is earlier than the date the Fund is calculating its NAV. This factor may result in a difference between the value of the investment and the price the Fund could receive upon the sale of the investment.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that the Fund has the ability to access;

 

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market–corroborated inputs); and

 

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by Private Companies that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

 

4.

SECURITIES AND OTHER INVESTMENTS

Preferred Stocks: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well), but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuer’s board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.

Securities Lending: The Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by the Fund is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund, or excess collateral returned by the Fund, on the next business day. During the term of the loan, the Fund is entitled to all distributions made on or in respect of the loaned securities, but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (“BIM”), if any, is disclosed in the Schedule of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are disclosed in the Fund’s Schedule of Investments. The market value of any securities on loan and the value of related collateral, if any, are shown separately in the Statement of Assets and Liabilities as a component of investments at value – unaffiliated and collateral on securities loaned, respectively.

Securities lending transactions are entered into by the Fund under Master Securities Lending Agreements (each, an “MSLA”), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Fund can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

 

 

N O T E S T O F I N A N C I A L S T A T E M E N T S

  27


Notes to Financial Statements (unaudited) (continued)

 

As of period end, the following table is a summary of the Fund’s securities on loan by counterparty which are subject to offset under an MSLA:

 

Counterparty    
Securities
Loaned at Value
 
 
    
Cash
Collateral Received
 
(a) 
   

Non-Cash
Collateral Received,
at Fair Value
 
 
(a)  
   
Net
Amount
 
 

BofA Securities, Inc.

  $ 2,212,952      $ (2,212,952   $     $  

Citigroup Global Markets, Inc.

    46,383        (46,383            

Credit Suisse Securities (USA) LLC

    121,066        (121,066            

Goldman Sachs & Co. LLC

    11,804,001        (11,804,001            

J.P. Morgan Securities LLC

    3,033,726        (3,033,726            

Jefferies LLC

    473,649        (473,649            

National Financial Services LLC

    156,128        (156,128            

State Street Bank & Trust Co.

    251,600        (251,600            

TD Prime Services LLC

    99,268        (99,268            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 18,198,773      $ (18,198,773   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Collateral received, if any, in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by the Fund is disclosed in the Fund’s Statement of Assets and Liabilities.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Fund benefits from a borrower default indemnity provided by BIM. BIM’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value on the securities loaned in the event of borrower default. The Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by the Fund.

 

5.

DERIVATIVE FINANCIAL INSTRUMENTS

The Fund engages in various portfolio investment strategies using derivative contracts both to increase the returns of the Fund and/or to manage its exposure to certain risks such as credit risk, equity risk, interest rate risk, foreign currency exchange rate risk, commodity price risk or other risks (e.g., inflation risk). Derivative financial instruments categorized by risk exposure are included in the Schedule of Investments. These contracts may be transacted on an exchange or over-the-counter (“OTC”).

Futures Contracts: Futures contracts are purchased or sold to gain exposure to, or manage exposure to, changes in interest rates (interest rate risk) and changes in the value of equity securities (equity risk) or foreign currencies (foreign currency exchange rate risk).

Futures contracts are exchange-traded agreements between the Fund and a counterparty to buy or sell a specific quantity of an underlying instrument at a specified price and on a specified date. Depending on the terms of a contract, it is settled either through physical delivery of the underlying instrument on the settlement date or by payment of a cash amount on the settlement date. Upon entering into a futures contract, the Fund is required to deposit initial margin with the broker in the form of cash or securities in an amount that varies depending on a contract’s size and risk profile. The initial margin deposit must then be maintained at an established level over the life of the contract. Amounts pledged, which are considered restricted, are included in cash pledged for futures contracts in the Statement of Assets and Liabilities.

Securities deposited as initial margin are designated in the Schedule of Investments and cash deposited, if any, are shown as cash pledged for futures contracts in the Statement of Assets and Liabilities. Pursuant to the contract, the Fund agrees to receive from or pay to the broker an amount of cash equal to the daily fluctuation in market value of the contract (“variation margin”). Variation margin is recorded as unrealized appreciation (depreciation) and, if any, shown as variation margin receivable (or payable) on futures contracts in the Statement of Assets and Liabilities. When the contract is closed, a realized gain or loss is recorded in the Statement of Operations equal to the difference between the notional amount of the contract at the time it was opened and the notional amount at the time it was closed. The use of futures contracts involves the risk of an imperfect correlation in the movements in the price of futures contracts and interest rates, foreign currency exchange rates or underlying assets.

 

6.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory: The Trust, on behalf of the Fund, entered into an Investment Advisory Agreement with the Manager, the Fund’s investment adviser and an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”), to provide investment advisory services. The Manager is responsible for the management of the Fund’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of the Fund.

For such services, the Fund pays the Manager a monthly fee at an annual rate equal to the following percentages of the average daily value of the Fund’s net assets:

 

Average Daily Net Assets   Investment Advisory Fees  

First $1 billion

    0.45

$1 billion — $3 billion 

    0.42  

$3 billion — $5 billion 

    0.41  

$5 billion — $10 billion 

    0.39  

Greater than $10 billion

    0.38  

 

 

28  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

Service and Distribution Fees: The Trust, on behalf of the Fund, entered into a Distribution Agreement and a Distribution and Service Plan with BlackRock Investments, LLC (“BRIL”), an affiliate of the Manager. Pursuant to the Distribution and Service Plan and in accordance with Rule 12b-1 under the 1940 Act, the Fund pays BRIL ongoing service and distribution fees. The fees are accrued daily and paid monthly at annual rates based upon the average daily net assets of the relevant share class of the Fund as follows:

 

Share Class   Service Fees      Distribution Fees  

Investor A

    0.25      N/A  

Class R

    0.25        0.25

BRIL and broker-dealers, pursuant to sub-agreements with BRIL, provide shareholder servicing and distribution services to the Fund. The ongoing service and/or distribution fee compensates BRIL and each broker-dealer for providing shareholder servicing and/or distribution related services to shareholders.

For the six months ended March 31, 2024, the following table shows the class specific service and distribution fees borne directly by each share class of the Fund:

 

     Investor A        Class R        Total  

Service and distribution — class specific

  $  188,677        $  17,988        $  206,665  

Administration: The Trust, on behalf of the Fund, entered into an Administration Agreement with the Manager, an indirect, wholly-owned subsidiary of BlackRock, to provide administrative services. For these services, the Manager receives an administration fee computed daily and payable monthly, based on a percentage of the average daily net assets of the Fund. The administration fee, which is shown as administration in the Statement of Operations, is paid at the annual rates below.

 

Average Daily Net Assets   Administration Fees  

First $500 million

    0.0425

$500 million - $1 billion

    0.0400  

$1 billion - $2 billion

    0.0375  

$2 billion - $4 billion

    0.0350  

$4 billion - $13 billion

    0.0325  

Greater than $13 billion

    0.0300  

In addition, the Manager charges each of the share classes an administration fee, which is shown as administration — class specific in the Statement of Operations, at an annual rate of 0.02% of the average daily net assets of each respective class.

For the six months ended March 31, 2024, the following table shows the class specific administration fees borne directly by each share class of the Fund:

 

     Institutional        Investor A        Class K        Class R        Total  

Administration — class specific

  $ 33,192        $ 15,075        $ 4,310        $ 718        $  53,295  

Transfer Agent: Pursuant to written agreements, certain financial intermediaries, some of which may be affiliates, provide the Fund with sub-accounting, recordkeeping, sub-transfer agency and other administrative services with respect to servicing of underlying investor accounts. For these services, these entities receive an asset-based fee or an annual fee per shareholder account, which will vary depending on share class and/or net assets. For the six months ended March 31, 2024, the Fund paid $10,400 for the Fund’s Institutional Shares to affiliates of BlackRock in return for these services, which are included in transfer agent — class specific in the Statement of Operations.

The Manager maintains a call center that is responsible for providing certain shareholder services to the Fund. Shareholder services include responding to inquiries and processing purchases and sales based upon instructions from shareholders. For the six months ended March 31, 2024, the Fund reimbursed the Manager the following amounts for costs incurred in running the call center, which are included in transfer agent — class specific in the Statement of Operations:

 

     Institutional        Investor A        Class K        Class R        Total  

Reimbursed amounts

  $ 720        $ 8,352        $ 79        $ 77        $  9,228  

For the six months ended March 31, 2024, the following table shows the class specific transfer agent fees borne directly by each share class of the Fund:

 

     Institutional        Investor A        Class K        Class R        Total  

Transfer agent — class specific

  $ 296,159        $ 146,472        $ 7,142        $ 8,102        $  457,875  

Other Fees: For the six months ended March 31, 2024, affiliates earned underwriting discounts, direct commissions and dealer concessions on sales of the Fund’s Investor A Shares for a total of $2,216.

For the six months ended March 31, 2024, affiliates received CDSCs in the amount of $485 for Investor A Shares

Expense Limitations, Waivers and Reimbursements: The Manager contractually agreed to waive its investment advisory fees by the amount of investment advisory fees the Fund pays to the Manager indirectly through its investment in affiliated money market funds (the “affiliated money market fund waiver”) through June 30, 2025. The contractual agreement may be terminated upon 90 days’ notice by a majority of the trustees who are not “interested persons” of the Trust, as defined in the 1940 Act (“Independent Trustees”), or by a vote of a majority of the outstanding voting securities of the Fund. The amount of waivers and/or reimbursements of fees and expenses made pursuant to the expense limitation described below will be reduced by the amount of the affiliated money market fund waiver. This amount is included in fees waived and/or reimbursed by the Manager in the Statement of Operations. For the six months ended March 31, 2024, the amount waived was $1,911.

 

 

N O T E S T O F I N A N C I A L S T A T E M E N T S

  29


Notes to Financial Statements (unaudited) (continued)

 

The Manager has contractually agreed to waive its investment advisory fee with respect to any portion of the Fund’s assets invested in affiliated equity and fixed-income mutual funds and affiliated exchange-traded funds that have a contractual management fee through June 30, 2025. The contractual agreement may be terminated upon 90 days’ notice by a majority of the Independent Trustees, or by a vote of a majority of the outstanding voting securities of the Fund. For the six months ended March 31, 2024, there were no fees waived by the Manager pursuant to this arrangement.

The Manager contractually agreed to waive and/or reimburse fees or expenses in order to limit expenses, excluding interest expense, dividend expense, tax expense, acquired fund fees and expenses, and certain other fund expenses, which constitute extraordinary expenses not incurred in the ordinary course of the Fund’s business (“expense limitation”). The expense limitations as a percentage of average daily net assets are as follows:

 

Institutional      Investor A        Class K        Class R  

  0.50%

       0.75        0.45        1.00

The Manager has agreed not to reduce or discontinue the contractual expense limitations through June 30, 2025, unless approved by the Board, including a majority of the Independent Trustees, or by a vote of a majority of the outstanding voting securities of the Fund. For the six months ended March 31, 2024, the Manager waived and/or reimbursed investment advisory fees of $355,360, which is included in fees waived and/or reimbursed by the Manager in the Statement of Operations.

In addition, these amounts waived and/or reimbursed by the Manager are included in administration fees waived by the Manager — class specific and transfer agent fees waived and/or reimbursed by the Manager — class specific, respectively, in the Statement of Operations. For the six months ended March 31, 2024, class specific expense waivers and/or reimbursements were as follows:

 

      Institutional      Investor A      Class K      Class R      Total  

Administration fees waived by the Manager — class specific

   $ 33,192      $ 15,075      $ 4,310      $ 719      $ 53,296  

Transfer agent fees waived and/or reimbursed by the Manager — class specific

     213,173        109,197        7,142        6,334        335,846  

Securities Lending: The U.S. Securities and Exchange Commission (“SEC”) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Fund, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan (the “collateral investment fees”). The cash collateral is invested in a money market fund, BlackRock Cash Funds: Institutional, managed by the Manager or its affiliates. However, BIM has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees the Fund bears to an annual rate of 0.04%. The SL Agency Shares of such money market fund will not be subject to a sales load, redemption fee, distribution fee or service fee. The money market fund in which the cash collateral has been reinvested may impose a discretionary liquidity fee of up to 2% of the value redeemed, if such fee, is determined to be in the best interests of such money market fund.

Securities lending income is generally equal to the total of income earned from the reinvestment of cash collateral, (and excludes collateral investment fees), and any fees or other payments to and from borrowers of securities. The Fund retains a portion of the securities lending income and remits the remaining portion to BIM as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, the Fund retains 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Multi-Asset Complex in a calendar year exceeds a specified threshold, the Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

The share of securities lending income earned by the Fund is shown as securities lending income — affiliated — net in the Statement of Operations. For the six months ended March 31, 2024, the Fund paid BIM $9,208 for securities lending agent services.

Trustees and Officers: Certain trustees and/or officers of the Trust are directors and/or officers of BlackRock or its affiliates. The Fund reimburses the Manager for a portion of the compensation paid to the Trust’s Chief Compliance Officer, which is included in Trustees and Officer in the Statement of Operations.

Other Transactions: The Fund may purchase securities from, or sell securities to, an affiliated fund provided the affiliation is due solely to having a common investment adviser, common officers, or common trustees. For the six months ended March 31, 2024, the purchase and sale transactions and any net realized gains (losses) with an affiliated fund in compliance with Rule 17a-7 under the 1940 Act were as follows:

 

Purchases      Sales        Net Realized
Gain
 

$ 8,383,230

     $ 12,802,858        $ 236,576  

 

7.

PURCHASES AND SALES

For the six months ended March 31, 2024, purchases and sales of investments, excluding short-term securities, were $336,805,029 and $354,619,751, respectively.

 

 

30  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

8.

INCOME TAX INFORMATION

It is the Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

The Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on the Fund’s U.S. federal tax returns generally remains open for a period of three years after they are filed. The statutes of limitations on the Fund’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.

Management has analyzed tax laws and regulations and their application to the Fund as of March 31, 2024, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Fund’s financial statements.

As of September 30, 2023, the Fund had non-expiring capital loss carryforwards available to offset future realized capital gains of $102,888,721.

As of March 31, 2024, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

 

 
    Amounts  

 

 

Tax cost

  $ 513,167,051  
 

 

 

 

Gross unrealized appreciation

  $ 123,059,493  

Gross unrealized depreciation

    (23,761,100
 

 

 

 

Net unrealized appreciation (depreciation)

  $   99,298,393  
 

 

 

 

 

 

 

9.

BANK BORROWINGS

The Trust, on behalf of the Fund, along with certain other funds managed by the Manager and its affiliates (“Participating Funds”), is party to a 364-day, $2.50 billion credit agreement with a group of lenders. Under this agreement, the Fund may borrow to fund shareholder redemptions. Excluding commitments designated for certain individual funds, the Participating Funds, including the Fund, can borrow up to an aggregate commitment amount of $1.75 billion at any time outstanding, subject to asset coverage and other limitations as specified in the agreement. The credit agreement has the following terms: a fee of 0.10% per annum on unused commitment amounts and interest at a rate equal to the higher of (a) Overnight Bank Funding Rate (“OBFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.80% per annum, (b) the Fed Funds rate (but, in any event, not less than 0.00%) in effect from time to time plus 0.80% per annum on amounts borrowed or (c) the sum of (x) Daily Simple Secured Overnight Financing Rate (“SOFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.10% and (y) 0.80% per annum. The agreement expires in April 2024 unless extended or renewed. These fees were allocated among such funds based upon portions of the aggregate commitment available to them and relative net assets of Participating Funds. During the six months ended March 31, 2024, the Fund did not borrow under the credit agreement.

 

10.

PRINCIPAL RISKS

In the normal course of business, the Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Fund and its investments. The Fund’s prospectus provides details of the risks to which the Fund is subject.

The Fund may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to discretionary liquidity fees under certain circumstances.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. The Fund may invest in illiquid investments. An illiquid investment is any investment that the Fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. The Fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause the Fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of the Fund may lose value, regardless of the individual results of the securities and other instruments in which the Fund invests.

The price the Fund could receive upon the sale of any particular portfolio investment may differ from the Fund’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Fund’s results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by the Fund, and the Fund could realize a greater than expected loss or lesser than expected gain upon the sale of the investment. The Fund’s ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third-party service providers.

 

 

N O T E S T O F I N A N C I A L S T A T E M E N T S

  31


Notes to Financial Statements (unaudited) (continued)

 

Counterparty Credit Risk: The Fund may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Fund manages counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Fund to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Fund’s exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statement of Assets and Liabilities, less any collateral held by the Fund.

A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.

With exchange-traded futures, there is less counterparty credit risk to the Fund since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, the Fund does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded futures with respect to initial and variation margin that is held in a clearing broker’s customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing broker’s customers, potentially resulting in losses to the Fund.

Geographic/Asset Class Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within the Fund’s portfolio are disclosed in its Schedule of Investments.

The Fund invests a significant portion of its assets in securities within a single or limited number of market sectors. When a Fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the Fund and could affect the income from, or the value or liquidity of, the Fund’s portfolio. Investment percentages in specific sectors are presented in the Schedule of Investments.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

 

11.

CAPITAL SHARE TRANSACTIONS

Transactions in capital shares for each class were as follows:

 

     Six Months Ended 03/31/24     Year Ended 09/30/23  
Share Class   Shares     Amount     Shares     Amount  

Institutional

       

Shares sold

    2,254,083     $ 40,298,806       4,465,433     $ 74,794,063  

Shares issued in reinvestment of distributions

    42,643       741,558       76,411       1,295,932  

Shares redeemed

    (2,268,695     (40,830,581     (6,132,423     (103,740,779
 

 

 

   

 

 

   

 

 

   

 

 

 
    28,031     $ 209,783       (1,590,579   $ (27,650,784
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold and automatic conversion of shares

    725,706     $ 8,364,575       1,384,805     $ 14,706,544  

Shares issued in reinvestment of distributions

    25,647       280,839       73,507       786,533  

Shares redeemed

    (2,399,266     (27,436,211     (2,927,820     (31,070,783
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,647,913   $ (18,790,797     (1,469,508   $ (15,577,706
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    393,331     $ 7,023,001       714,064     $ 11,986,320  

Shares issued in reinvestment of distributions

    7,173       124,658       10,941       185,452  

Shares redeemed

    (364,534     (6,658,890     (643,175     (10,851,855
 

 

 

   

 

 

   

 

 

   

 

 

 
    35,970     $ 488,769       81,830     $ 1,319,917  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    67,801     $ 771,548       177,819     $ 1,927,376  

Shares issued in reinvestment of distributions

                1,514       16,241  

Shares redeemed

    (105,344     (1,207,841     (233,619     (2,531,072
 

 

 

   

 

 

   

 

 

   

 

 

 
    (37,543   $ (436,293     (54,286   $ (587,455
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,621,455   $ (18,528,538     (3,032,543   $ (42,496,028
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

32  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Notes to Financial Statements (unaudited) (continued)

 

12.

SUBSEQUENT EVENTS

Management’s evaluation of the impact of all subsequent events on the Fund’s financial statements was completed through the date the financial statements were issued and the following item was noted:

Effective April 11, 2024, the 364-day credit agreement to which BlackRock FundsSM, on behalf of the Fund, and the Participating Funds are party, was amended to (i) decrease the aggregate commitment amount to $2.40 billion, and (ii) extend the termination date to April 2025.

 

 

N O T E S T O F I N A N C I A L S T A T E M E N T S

  33


Statement Regarding Liquidity Risk Management Program

 

In compliance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), BlackRock FundsSM (the “Trust”) has adopted and implemented a liquidity risk management program (the “Program”) for BlackRock Advantage Small Cap Growth Fund (the “Fund”), a series of the Trust, which is reasonably designed to assess and manage the Fund’s liquidity risk.

The Board of Trustees (the “Board”) of the Trust, on behalf of the Fund, met on November 16-17, 2023 (the “Meeting”) to review the Program. The Board previously appointed BlackRock Advisors, LLC or BlackRock Fund Advisors (“BlackRock”), each an investment adviser to certain BlackRock funds, as the program administrator for the Fund’s Program, as applicable. BlackRock also previously delegated oversight of the Program to the 40 Act Liquidity Risk Management Committee (the “Committee”). At the Meeting, the Committee, on behalf of BlackRock, provided the Board with a report that addressed the operation of the Program and assessed its adequacy and effectiveness of implementation, including the management of the Fund’s Highly Liquid Investment Minimum (“HLIM”) where applicable, and any material changes to the Program (the “Report”). The Report covered the period from October 1, 2022 through September 30, 2023 (the “Program Reporting Period”).

The Report described the Program’s liquidity classification methodology for categorizing the Fund’s investments (including derivative transactions) into one of four liquidity buckets. It also referenced the methodology used by BlackRock to establish the Fund’s HLIM and noted that the Committee reviews and ratifies the HLIM assigned to the Fund no less frequently than annually. The Report also discussed notable events affecting liquidity over the Program Reporting Period, including the imposition of capital controls in certain countries.

The Report noted that the Program complied with the key factors for consideration under the Liquidity Rule for assessing, managing and periodically reviewing the Fund’s liquidity risk, as follows:

 

  a)

The Fund’s investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed whether the Fund’s strategy is appropriate for an open-end fund structure with a focus on funds with more significant and consistent holdings of less liquid and illiquid assets. The Committee also factored a fund’s concentration in an issuer into the liquidity classification methodology by taking issuer position sizes into account. Where a fund participated in borrowings for investment purposes (such as tender option bonds or reverse repurchase agreements), such borrowings were factored into the Program’s calculation of a fund’s liquidity bucketing. A fund’s derivative exposure was also considered in such calculation.

 

  b)

Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed historical redemption activity and used this information as a component to establish the Fund’s reasonably anticipated trading size utilized for liquidity classifications. The Fund has adopted an in-kind redemption policy which may be utilized to meet larger redemption requests. The Committee may also take into consideration a fund’s shareholder ownership concentration (which, depending on product type and distribution channel, may or may not be available), a fund’s distribution channels, and the degree of certainty associated with a fund’s short-term and long-term cash flow projections.

 

  c)

Holdings of cash and cash equivalents, as well as borrowing arrangements. The Committee considered the terms of the credit facility committed to the Fund, the financial health of the institution providing the facility and the fact that the credit facility is shared among multiple funds (including that a portion of the aggregate commitment amount is specifically designated for BlackRock Floating Rate Income Portfolio, a series of BlackRock Funds V, and BlackRock Floating Rate Loan ETF, a series of BlackRock ETF Trust II). The Committee also considered other types of borrowing available to the funds, such as the ability to use reverse repurchase agreements and interfund lending, as applicable.

There were no material changes to the Program during the Program Reporting Period other than the enhancement of certain model components in the Program’s classification methodology. The Report provided to the Board stated that the Committee concluded that based on the operation of the functions, as described in the Report, the Program is operating as intended and is effective in implementing the requirements of the Liquidity Rule.

 

 

34  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Additional Information

 

Tailored Shareholder Reports for Open-End Mutual Funds and ETFs

Effective January 24, 2023, the SEC adopted rule and form amendments to require open-end mutual funds and ETFs to transmit concise and visually engaging streamlined annual and semiannual reports to shareholders that highlight key information. Other information, including financial statements, will no longer appear in a streamlined shareholder report but must be available online, delivered free of charge upon request, and filed on a semiannual basis on Form N-CSR. The rule and form amendments have a compliance date of July 24, 2024. At this time, management is evaluating the impact of these amendments on the shareholder reports for the Fund.

General Information

Quarterly performance, semi-annual and annual reports, current net asset value and other information regarding the Fund may be found on BlackRock’s website, which can be accessed at blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate BlackRock’s website in this report.

Householding

The Fund will mail only one copy of shareholder documents, including prospectuses, annual and semi-annual reports, Rule 30e-3 notices and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called “householding” and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Fund at (800) 441-7762.

Availability of Quarterly Schedule of Investments

The Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The Fund’s Form N-PORT is available on the SEC’s website at sec.gov. Additionally, the Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at blackrock.com/fundreports.

Availability of Proxy Voting Policies, Procedures and Voting Records

A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities and information about how the Fund voted proxies relating to securities held in the Fund’s portfolio during the most recent 12-month period ended June 30 is available without charge, upon request (1) by calling (800) 441-7762; (2) on the BlackRock website at blackrock.com; and (3) on the SEC’s website at sec.gov.

BlackRock’s Mutual Fund Family

BlackRock offers a diverse lineup of open-end mutual funds crossing all investment styles and managed by experts in equity, fixed-income and tax-exempt investing. Visit blackrock.com for more information.

Shareholder Privileges

Account Information

Call us at (800) 441-7762 from 8:00 AM to 6:00 PM ET on any business day to get information about your account balances, recent transactions and share prices. You can also visit blackrock.com for more information.

Automatic Investment Plans

Investor class shareholders who want to invest regularly can arrange to have $50 or more automatically deducted from their checking or savings account and invested in any of the BlackRock funds.

Systematic Withdrawal Plans

Investor class shareholders can establish a systematic withdrawal plan and receive periodic payments of $50 or more from their BlackRock funds, as long as their account balance is at least $10,000.

Retirement Plans

Shareholders may make investments in conjunction with Traditional, Rollover, Roth, Coverdell, Simple IRAs, SEP IRAs and 403(b) Plans.

BlackRock Privacy Principles

BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, “Clients”) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.

 

 

A D D I T I O N A L I N F O R M A T I O N

  35


Additional Information (continued)

 

If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.

BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.

BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.

We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.

Fund and Service Providers

 

Investment Adviser and Administrator

BlackRock Advisors, LLC

Wilmington, DE 19809

Accounting Agent and Transfer Agent

BNY Mellon Investment Servicing (US) Inc.

Wilmington, DE 19809

Custodian

The Bank of New York Mellon

New York, NY 10286

Independent Registered Public Accounting Firm

Deloitte & Touche LLP

Boston, MA 02116

Distributor

BlackRock Investments, LLC

New York, NY 10001

Legal Counsel

Sidley Austin LLP

New York, NY 10019

Address of the Trust

100 Bellevue Parkway

Wilmington, DE 19809

 

 

 

36  

2 0 2 4 B L A C K R O C K S E M I  - A N N U A L R E P O R T T O S H A R E H O L D E R S


Glossary of Terms Used in this Report

 

Portfolio Abbreviation

CVR    Contingent Value Rights
LP    Limited Partnership
NVS    Non-Voting Shares
 

 

 

G L O S S A R Y O F T E R M S U S E D I N T H I S  R E P O R T

  37


 

 

THIS PAGE INTENTIONALLY LEFT BLANK.

 

 

 

 


 

 

THIS PAGE INTENTIONALLY LEFT BLANK.

 

 

 

 


 

 

 

 

Want to know more?

blackrock.com | 800-441-7762

This report is intended for current holders. It is not authorized for use as an offer of sale or a solicitation of an offer to buy shares of the Fund unless preceded or accompanied by the Fund’s current prospectus. Past performance results shown in this report should not be considered a representation of future performance. Investment returns and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are as dated and are subject to change.

ASCG-03/24-SAR

 

LOGO

  LOGO


(b) Not Applicable

 

Item 2 –

Code of Ethics – Not Applicable to this semi-annual report

 

Item 3 –

Audit Committee Financial Expert – Not Applicable to this semi-annual report

 

Item 4 –

Principal Accountant Fees and Services – Not Applicable to this semi-annual report

 

Item 5 –

Audit Committee of Listed Registrant – Not Applicable

 

Item 6 –

Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1(a) of this Form.

(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.

 

Item 7 –

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – Not Applicable

 

Item 8 –

Portfolio Managers of Closed-End Management Investment Companies – Not Applicable

 

Item 9 –

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable

 

Item 10 –

Submission of Matters to a Vote of Security Holders –There have been no material changes to these procedures.

 

Item 11 –

Controls and Procedures

(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12 –

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies – Not Applicable

 

Item 13 –

Recovery of Erroneously Awarded Compensation – Not Applicable

 

Item 14 –

Exhibits attached hereto

(a)(1) Code of Ethics – Not Applicable to this semi-annual report

(a)(2) Section 302 Certifications are attached

 

2


(a)(3) Any written solicitation to purchase securities under Rule 23c-1 – Not Applicable

(a)(4) Change in Registrant’s independent public accountant – Not Applicable

(b) Section 906 Certifications are attached

 

3


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BlackRock FundsSM

 

 

By:

    

/s/ John M. Perlowski       

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock FundsSM

Date: May 22, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

    

/s/ John M. Perlowski       

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock FundsSM

Date: May 22, 2024

 

 

By:

    

/s/ Trent Walker          

      

Trent Walker

      

Chief Financial Officer (principal financial officer) of

      

BlackRock FundsSM

Date: May 22, 2024

 

4